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 Assembly of an infectious retroviral particle (virion) involves a set of events, 
including multimerization of thousands of Gag proteins, packaging of two copies of 
genomic RNA, and Gag interaction with the plasma membrane. While each of these 
events can be thought of as discrete, they are dependent on one another. The Gag 
polyprotein has three major domains: the N-terminal membrane-binding domain (MA), 
the central assembly domain (CA), and the C-terminal nucleic acid (or genomic RNA) 
binding domain (NC). According to one model for formation of virions, NC binds to 
genomic RNA, which promotes Gag multimerization, which in turn enhances membrane 
interactions. The work described in this thesis focuses on two aspects of this model, the 
response of Gag to lipids with different head groups and acyl chains, and the effect of 
multimerization of Gag on its interaction with membranes.  
In a comparative study of Rous sarcoma virus (RSV) and human 
immunodeficiency virus type-1 (HIV-1) Gag, we found that, unlike HIV-1 Gag, RSV Gag 
was not dependent on the lipid phosphatidylinositol-4,5-phosphate (PI(4,5)P2) for 
membrane interaction and virus release in vivo. However, both Gag proteins had a 
similar response to mono-, di, and tri-phosphorylated phosphatidylinositols (PIPs) by an 
in vitro liposome flotation assay. I interpret these findings to suggest that in addition to 
	  	  
	  
	  
the specific interaction reported for HIV-1 Gag, PIPs enhance Gag membrane binding 
electrostatically. In a follow-up study I found that increasing the concentration of 
phosphatidylserine (PS) in the membrane resulted in dramatically more HIV-1 Gag 
binding, and this response to PS was modulated by the lipid acyl chains. Also, the 
presence of cholesterol in the membrane significantly increased the amount of Gag 
associated with the liposomes. I interpret these results to mean that Gag can sense the 
hydrophobic core of the lipid bilayer. To determine the effect of Gag multimerization on 
its binding to membranes, monomeric, dimeric, and hexameric MA chimeras were 
tested. In vivo and in vitro, increasing the multimeric state of MA increased its 
localization to the plasma membrane and to liposomes. These findings suggest that 
Gag binding to the plasma membrane is enhanced by multimerization. 	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BIOGRAPHICAL SKETCH 
I havenʼt always known that science was right for me. In fact, I graduated High 
school with grades so low that going to college wasnʼt even an option. It wasnʼt that 
opportunities werenʼt available or that my parents didnʼt impress upon me the 
importance of education, but that I just lost my way. After high school graduation it was 
a struggle to pay my bills. Working multiple part time and full time jobs at once was 
barely enough. I wanted more out of life, so I enrolled in the local community college 
and two years later transferred to Iowa State University. The plan was to earn a degree 
in genetics and then go to law school. Patent law in an emerging industry seemed the 
best way to a six-figured salary from my point of view. But goals change. During the 
summer of my first research internship I was seduced by science. My new aim was to 
attend graduate school and pursue a career in scientific research. 
As an undergrad I earned two NSF REU summer internship awards, one in the 
lab of Dr. Dan Voytas at Iowa State University and the second in the lab of Dr. Jian-
Kang Zhu at the University of California Riverside. My summer project in the Voytas lab 
focused on Arabidopsis. I worked to characterize tissue expression of a family of light 
chain dynein motor proteins. The following summer, in the lab of Dr. Zhu, I worked to 
identify genes involved in DNA de-methylation. I also studied abiotic stress in plants by 
identifying mutants with decreased abscisic acid (ABA), a key component of stress 
response signaling. 
Following my summer internship in the Voytas lab, Dr. Voytas asked me to join 
his group as an undergraduate researcher. I jumped at the opportunity. My 
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undergraduate research project, which was related to my masterʼs thesis project, was 
the study of the yeast retrotransposable element Ty5. I performed yeast-two-hybrid 
analysis to identify amino acids that were important for the interaction between the 
retroelementʼs integrase protein and the yeast protein Sir4, a chromatin silencing 
complex protein. This research led to the identification of a cellular analog, Esc1, which 
had a domain homologous to Ty5 integrase. 
After completion of my MS I moved to NY where I had been accepted to Cornell 
Universityʼs Biochemistry, Molecular and Cell Biology PhD program. Following the first 
year of course work and research rotations I joined the lab of Dr. Volker Vogt to study 
retroviral genomic RNA packaging. For about a year I worked to characterize the 
interaction between the genomic RNA packaging signal (Psi) and the C-terminal end of 
the retroviral structural protein, Gag. During this time I not only learned about RNA 
structure and function, I also learned many techniques necessary to handle, prepare 
and study both RNA and protein. However, as I worked on this project, I became 
interested in something else, the interaction between Gag and membranes. For the 
remainder of my PhD I worked to characterize this interaction. 
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CHAPTER 1 
INTRODUCTION  
ENVELOPED VIRUSES 
All retroviruses are enveloped, a common characteristic of many animal viruses. 
The viral envelope is a lipid bilayer derived from the host cell. The acquisition of a viral 
envelope is a strategy employed by both RNA and DNA viruses to protect their genome. 
Many enveloped viruses are linked to human pathogenicity including the RNA virus 
influenza, a member of the family Orthomyxoviridae, the DNA virus smallpox, a member 
of the family Poxviridae, and the retrovirus responsible for acquired immunodeficiency 
syndrome (AIDS), human immunodeficiency virus (HIV-1). The viral envelope is not only 
composed of lipids but also has embedded in it the viral fusion glycoproteins and small 
amounts of cellular membrane-associated proteins. The glycoproteins serve to direct 
viruses to the correct host cell by specific interactions with receptor proteins, and to 
mediate fusion. This interaction leads to structural changes in the glycoprotein that 
provide some of the energy required for fusion between viral and host cell membranes. 
Acquisition of the viral envelope is a coordinated process that involves viral and 
cellular proteins. Most retroviruses acquire their envelope from the plasma membrane 
(PM) of the host cell. The Simian foamy virus (SFV), from the genus Spumarirus, is an 
exception to the rule. Foamy viruses, named because of the characteristic foamy 
appearance of infected cells, bud into the endoplasmic reticulum and are then likely 
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exocytosed into the extracellular space. Membrane acquisition from cellular membranes 
other than the PM is not uncommon for non-retroviruses. 
Because enveloped viruses are more sensitive to desiccation and heat than are 
non-enveloped viruses, they typically require host-host contact for transmission. For 
example, HIV-1 requires fluid-fluid contact between hosts. The most common 
transmission routes for HIV are sexual contact, blood transfusions, and sharing of 
needles between intravenous drug users. Decreasing the spread of HIV-1 has been 
accomplished by increasing the use of condoms, blood screening, and clean needle 
programs. However, in developing countries, these simple measures have proven to be 
difficult to implement, and therefore HIV-1 continues to be a major threat to human 
health.  
 
RETROVIRAL PATHOGENESIS 
 According to the world health organization, while the number of deaths is on a 
steady decline, approximately thirty four million people are currently infected with HIV-1 
and two and a half million new infections are added annually. HIV-1 accounts for more 
than a million deaths a year. In comparison, flu accounts for one quarter to one half that 
number of deaths (151). Retroviruses cause many diseases including malignancies, 
immunodeficiencies, and neurologic disorders (54). It is clear that retroviruses represent 
a severe risk to human health, which is why it is so important that we study how they 
function. By understanding how retroviruses function we can better design drugs that 
minimize their spread. 
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 The lentivirus HIV-1 is the prime example of a retrovirus that causes 
immunodeficiency. In humans, HIV-1 infects and kills CD4-positive T-cells, which over 
the course of many years leads to severe impairment of the hostʼs immune system, a 
condition known as AIDS. AIDS is characterized by a low T cell count and an increase 
in the number of opportunistic infections not common in people with a healthy immune 
system, such as pneumonia. While a vaccine for HIV-1 remains elusive, extensive study 
into the molecular biology of HIV-1 has led to a number of different classes of 
antiretrovirals that, when used together (highly active antiretroviral therapy, HAART), 
have proven effective in preventing HIV-1 infection from progressing to AIDS. HAART is 
a cocktail of drugs that can include inhibitors of entry, reverse transcription, integration, 
and maturation. The cocktail is necessary because HIV rapidly escapes single blocks to 
its spread by having a large amount of genetic diversity. This diversity is a hallmark of 
retroviruses, and is caused by the error prone reverse transcriptase (RT), which 
generates roughly one mutation per viral genome. 
 Because of the threat to human health that retroviruses represent, it is important 
to continue to develop new strategies to combat them. By studying HIV-1 and model 
retroviruses like Rous sarcoma virus (RSV) and murine leukemia virus (MLV) we can 
characterize critical steps in the retroviral lifecycle that could be new targets for 
antiretrovirals.  
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RETROVIRAL GENOME 
 The retroviral genome is a single stranded RNA molecule between seven and 
twelve thousand bases in length (Fig. 1.1). The 5ʼ and 3ʼ ends of the genome are 
composed of untranslated regions (UTRs), which contain multiple elements critical to 
the virus. The primer-binding site (PBS), the packaging sequence (Psi), and the 
dimerization initiation site (DIS) are located in the 5ʼUTR. The PBS is a stretch of 
nucleotides that binds to a host cell tRNA which is required for initiation of reverse 
transcription. Psi and DIS direct genome packaging and dimerization, and both will be 
discussed in detail in a later section. 
Retroviruses can be split into two categories, simple or complex. The genomes of 
simple retroviruses, RSV for example, code for three genes: gag, pol, and env. Gag 
codes for the structural protein Gag and, in the case of RSV, protease (PR). Pol 
encodes the enzymatic proteins, integrase (IN), RT, and for most retroviruses, PR. Env 
encodes the transmembrane envelope glycoprotein Env, which is processed in the 
Golgi to yield the two subunits, the surface protein (SU) and the transmembrane protein 
(TM). In addition to the three major genes, complex retroviruses code for multiple 
accessory proteins that are involved in the trafficking of retroviral components in the cell 
and adaptation to cellular restriction factors that act to prevent viral spread.  
 
	   	   5	  
	  
	  
	  
 
Fig 1.1  RSV genome and the Gag polyprotein. The RSV genome codes for three 
genes and a 5ʼ and 3ʼ UTR, which contains elements required for reverse transcription 
and packaging. The Gag polyprotein is shown with protease cleavage sites indicated by 
vertical lines. The three major domains, MA, CA, and NC, common to all retroviruses 
are shown. Minor cleavage products for RSV Gag, p10 and SP are also shown. The 
UTRs are not drawn to scale. 
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RETROVIRAL LIFECYCLE 
 The retroviral lifecycle is a complex process that can be split into multiple steps, 
including fusion of the virus with the host cell, reverse transcription of the RNA genome 
into double stranded DNA (dsDNA), uncoating the viral core, integration of the dsDNA 
genome into the hostʼs genome, and assembly, budding and maturation of the new 
virion (virus particle) (Fig. 1.2). Each one of these steps is critical to successful 
propagation of the retrovirus. 
 The retroviral life cycle begins with the fusion of an infectious virus particle with a 
target cell. Also known as viral entry, fusion involves the interaction between the viral 
glycoprotein and a specific receptor protein located on the extracellular side of a target 
cellʼs plasma membrane. Different retroviruses recognize different receptors.
 Following interaction between the viral glycoprotein and the host cell receptor, 
fusion can proceed down one of two pathways. For some viruses, including RSV and 
influenza, the acidic environment of the endosome is required to activate the fusogenic 
properties of their glycoprotein complexes (54). However, most retroviruses undergo 
fusion without being endocytosed. Conformational changes in the viral glycoprotein lead 
to contact and fusion between the viral and cellular membrane.  
 The next step of viral entry is the release of the viral core into the cellʼs 
cytoplasmic space, which is followed by reverse transcription of the viral genomic RNA 
(vgRNA) by RT into dsDNA.  
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Fig 1.2  The retroviral life cycle (adapted from (54)). Viral entry is mediated by 
interaction of the viral Env to a specific cellular receptor protein. Reverse transcription 
results in a dsDNA that is integrated into the host DNA. Cell protein-mediated 
transcription and translation of viral RNA and protein lead to assembly of viral 
components at the inner leaflet of the plasma membrane. Recruitment of cellular 
ESCRT proteins to the budding site aids in the fission event that releases the virus 
particle into the extracellular space. The final step, known as maturation occurs during 
or following fission. Viral protease becomes active cleaving the viral Gag protein at 
multiple locations resulting in rearrangement of the Gag domain CA. CAs make new 
contacts forming the viral core. 
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It should be noted that the discovery of RT upended the central dogma of molecular 
biology, namely that DNA is always transcribed into RNA (and never the reverse), which 
is translated into protein. Because the process of reverse transcription is unique to 
retroviruses and retrotransposable elements, it is a prime target for antiretroviral 
therapy. 
 Reverse transcription is a complex process that involves multiple steps. The 
retroviral RNA enters the cytoplasm as part of a nucleoprotein complex, and reverse 
transcription is initiated at the 3ʼ end of a cellular tRNA, which is bound to the genomeʼs 
5ʼ PBS. This first round of RT activity results in the minus-strand strong-stop DNA (-
sssDNA) (54). Following RNase H degradation (RNase H is part of the reverse 
transcriptase enzyme) of the -sssDNA duplexed RNA, the -sssDNA segment transfers 
to the 3ʼ end of the genome mediated by identical sequence repeats in both the 5ʼ and 
3ʼ ends of the viral genome. The second round of reverse transcription results in the 
generation of a complete minus strand DNA. Next, RNase H degrades the template 
RNA except for a resistant short region, the polypurine tract (PPT). The PPT serves as 
the initiation site for the RT-generated plus-strand strong-stop DNA (+sssDNA). 
Following RNase H removal of the tRNA, –sssDNA circularizes and serves as a 
template for making +sssDNA resulting in dsDNA.  
 The next step of infection is the integration of the dsDNA into the host genome. 
Integration begins when the retroviral IN cleaves two nucleotides from each end of the 
dsDNA viral genome generating two 3ʼOH groups. The IN-dsDNA complex (or pre-
integration complex (PIC)) is then trafficked into the nucleus of the host cell where the 
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viral DNA 3ʼOH groups attack the phosphodiester backbone of the host genome. The 
integration generates a staggered break in the host DNA, which is then filled in by 
cellular proteins resulting in a short repeats of the hostʼs genome (54). Integration of the 
viral genome can be considered the last step in the establishment of viral infection. If an 
integrated genome does not disrupt essential coding sequences, and is never 
transcribed into mRNA, a host may suffer no consequences. 
 The site of retroviral genome integration is important both to the host and the 
virus. If the integration occurs in a region of the hostʼs genome that is transcriptionally 
inactive, the viral DNA may not be transcribed into mRNA. Viruses avoid dead-end 
integration by targeting transcriptionally active regions of the genome. For example, 
HIV-1 integrates preferentially into transcriptionally active genes throughout the cellʼs 
DNA, and MLV insertion is directed towards promoter regions (102, 112, 142, 146). 
Avian sarcoma leukosis virus (ASLV) shows less targeted integration behavior, with only 
a slight preference for integration into transcriptionally active regions detected (11, 112). 
Human T-lymphotropic virus (HTLV) is similar to ASLV, showing little to no preference 
for targeted site insertion (61). 
 To achieve targeted integration, HIV-1 IN interacts with the cellular protein 
LEDGF/p75. This interaction directs HIV-1 integration to regions of the host cell DNA 
that LEDGF/p75 interacts with (49). Cellular co-factors that direct integration of other 
retroviruses have yet to be identified. However, excellent examples of targeted 
integration do exist for the yeast retrotransposable elements Ty3 and Ty5. 
Retrotransposable elements are closely related to retroviruses, coding for proteins with 
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similar functions to Gag and Pol. However, they do not leave the host cell, and so they 
do not code for the envelope glycoprotein. Ty3 integrates selectively into regions 
adjacent to RNA Pol III start sites near the front of tRNA genes (54). Ty5 integrates 
preferentially into silenced regions of the yeast chromosome owing to interaction 
between IN and the chromatin silencing complex protein Sir4p (27, 161). 
 
VIRAL PARTICLE PRODUCTION 
In order for a virus to spread to other cells and host organisms it must form an 
infectious virus particle. Successful assembly of the virus particle requires the 
convergence of multiple viral components within the cell. These spatially and temporally 
controlled events include Gag trafficking to and interacting with the PM, Gag interacting 
with other Gag proteins, and Gag interacting with vgRNA. If any of these events is 
disrupted infectious virus particles will not be produced. The one component common to 
all of these events is the Gag polyprotein, which is the only retroviral protein required to 
form a virus particle. 
Function of Gag polyprotein domains  
The retroviral Gag polyprotein is a long, rod-like protein with three independently 
folded structures or domains. These three domains are common to all retroviruses, 
sharing a large degree of structural and functional, but not sequence, homology.  The N-
terminal domain is matrix (MA), followed by capsid (CA), and at the C-terminus, 
nucleocapsid (NC) (Fig. 1.1). During virus particle maturation, cleavage of the Gag  
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polyprotein by the retroviral protease results in genus-specific cleavage products. These 
specific regions are important for assembly and trafficking of Gag. 
Viral assembly and maturation 
Viral particle assembly is driven by interactions between Gag proteins, often 
referred to as Gag multimerization. In cells, efficient particle assembly only takes place 
when Gag has a membrane-binding domain, and membrane binding of Gag is only 
efficient when Gag multimerization takes place. What regions of Gag drive Gag-Gag 
interactions and how do these interactions lead to particle assembly? 
Before Gag cleavage by PR, the virus particle contains a lattice of Gag hexamers 
named the immature lattice. Gag-Gag interactions in the immature lattice, common to 
most retroviruses, occur via contacts between CAs. CA folds into two domains, the N-
terminal domain (NTD) and the C-terminal domain (CTD). Based on the mature CA 
lattice, people expected that the NTD-NTD contacts would hold the immature hexamer 
together, but actually a recent paper on MPMV electron cryotomography (Briggs et al), 
implies that it is primarily CTD-CTD contacts that hold the hexamer together, and NTD-
NTD and CTD-NTD contacts bridge between the hexamers, as if the molecular contacts 
are very different in CA and Gag (3). It has been proposed that the region immediately 
following CA, the spacer peptide (SP), is alpha helical and forms a six-helix bundle, 
which further stabilizes each hexamer (21, 159). While MLV Gag does not have a 
spacer peptide, it does have a domain that appears to be analogous to the SP helix, 
named the “charged assembly helix” or “electric wire” owing to its high number of 
charged residues (50). Mutational analysis and modeling strongly suggest that this 
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domain also forms a helix (50). Whether or not the putative helical domain immediately 
downstream or at the C-terminus of the CA domain forms a six helix bundle remains to 
be determined.  However, this domain is clearly a conserved structural component with 
a function that is critical to the formation of the immature virus particle. 
During or immediately following viral budding, PR becomes activated and cleaves 
the Gag polyprotein beginning the process named maturation. Maturation causes the 
rearrangement of contacts between CAs, which dramatically changes the lattice 
resulting in the formation of the viral core. The viral core is a lattice of CA hexamers and 
pentamers. The lattice has been well studied by electron cryo-tomography (cEMT) (17, 
28, 30, 103), electron crystallography (76). These studies provide low-resolution data 
about the contacts required to form the lattice. The low-resolution data were used to 
identify interfaces that could be stabilized by di-sulfide crosslinking. Crosslinking was 
then used to generate stable mature CA hexamers and pentamers which, when 
crystallized, resulted in high resolution structures of 2Å (129, 130) and 2.5Å resolution 
(131). Taken together, these studies reveal that CA hexamers are held together by CA-
CTD dimers and the lattice is stabilized by an interface between the CA-CTD and CA-
NTD (29, 129-131). Just as the assembly of the viral particle is required to form 
infectious virus particles, maturation is also required. Because these key steps are 
essential, they are both targets for antiretrovirals. One difference between immature and 
mature assembly is that only the former requires interactions with the plasma 
membrane. 
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Nucleocapsid and genome packaging 
Initiation of Gag-Gag interactions and multimerization may occur when Gag 
proteins bind their vgRNA in the cellular cytoplasm. Disruption of NC-RNA interactions 
disrupts localization of Gag to the plasma membrane. Because multimerization is linked 
to interaction with the PM it is important to have an understanding of the process of 
packaging.  
NC of most retroviruses, except spumaretroviruses, has one or two zinc knuckles 
(Znk,), similar to Zn-finger domains, characterized by a CCHC amino acid motif and a 
tightly bound Zn (57). Other than the Znk, the NC is unstructured. NC also contains 
multiple basic residues centered between and after the Znks. Disruption of the Znks 
does not abolish particle assembly in vivo or vitro but it does prevent vgRNA packaging 
(18). Packaging of vgRNA is a tightly controlled step late in the viral life cycle. Amino 
acids between or immediately following the second Znk interact with specific vgRNA 
secondary structures and nucleotides. These specific interactions ensure that 
retroviruses select their own RNA from the milieu of cellular RNA (reviewed in (57)). 
Interestingly, one way that NC and packaging sequences were characterized was the 
generation of Gag chimeras with the NC domain of a different retrovirus. For example, 
when the NC domain of MLV is replaced with that of HIV, the HIV vgRNA is 
preferentially packaged and vice versa (20, 164). A similar result is also obtained when 
the NC of RSV is swapped with that of MLV (69). Therefore, NC is the major domain 
required to ensure that a budding virus selects its vgRNA. 
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 Successful genome packaging requires NC recognition of unique features of the 
target viral genome. The packaging sequence, or Psi for short, is generally defined as 
the minimal sequence that supports incorporation of vgRNA into the viral particle, and is 
located in the 5ʼ untranslated region of the viral genome (57). Originally, a 160 
nucleotide minimal packaging sequence for RSV (named MPsi or MΨ) was identified 
that is capable of packaging RNA into virus particles at efficiencies that are only 2.6-fold 
lower than the intact genome (9). However, other studies showed that the third stem-
loop of MPsi was not important for packaging (8, 67) and a new 82 nucleotide minimal 
packaging sequence was defined, named μPsi (8). The structure of the μPsi sequence 
in complex with NC was elucidated by nuclear magnetic resonance (NMR), which 
identified key nucleotide and amino acid interactions (165). Many tools have been used 
to define the secondary structure and nucleotides of RSV Psi that are critical for 
packaging, including computer simulation, NMR analysis, and multiple binding and 
packaging assays (67, 98, 165).  
 NC also has chaperone activity that plays a role in reverse transcription of the 
vgRNA into dsDNA, and that is also important for genome dimerization (101, 136). 
Retroviral genome dimerization is initiated at the DIS. Genome dimerization spreads 
through the genome and one resulting stable structure is the dimer linkage structure 
(DLS) located downstream of Psi in the gag gene (16). The chaperone activity of NC 
lowers the activation energy required to fold nucleic acid into secondary structures that 
have a high number of nucleotide base pairs (135, 136). A series of assays aimed at 
tracking genome dimerization and packaging found that both were dependent on the 
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DIS, and 90% of budded virus particles contain vgRNA, which was always dimeric (48, 
64). Packaging is also not dependent on the size of the RNA but instead on the 
presence of two copies of the genome (116). An example of how retroviruses select a 
dimerized genome comes from work with MLV. MLV NC preferentially binds to single 
stranded UCUG sequences. Upon genome dimerization, there is a rearrangement of 
RNA secondary structure exposing multiple UCUG sites in and around Psi (58). This 
result suggests that in general Psi function will boil down to multiple binding sites, 
maybe with different affinities for NC. 
Other Gag cleavage products 
Smaller cleavage products of Gag are not as conserved as the three major ones. 
However, these domains serve critical functions for the viruses that do have them. For 
example, RSV Gag codes two regions, p2 and p10 before CA, and SP after CA. These 
domains are discussed in greater detail in other sections but briefly here. The p2 and 
p10 cleavage products each contain a late domain (63, 158, 160). P10 is also critical for 
viral particle assembly, by participating in and stabilizing the immature Gag lattice (127). 
The SP region (called SP1 in HIV-1), as previously discussed, which is inferred to be 
helical in the Gag lattice, is essential for particle formation, and may act to regulate 
maturation of the CA lattice.  
 
GAG INTERACTION WITH THE PLASMA MEMBRANE 
 How does Gag select the PM as the site of assembly and not the endoplasmic 
reticulum (ER) or Golgi? The answer likely lies in a series of signals that drive Gag 
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membrane binding. These signals include electrostatic interactions, binding pockets in 
MA that specifically recognize unique phospholipids, hydrophobic interactions with the 
core of membranes by post-translational modification of MA with fatty acid chains, and 
multimerization of Gag.  
The MA domains of retroviruses share a high degree of structural homology. The 
NTD of MA is composed of 5-6 major alpha helices that fold into a globular shape (86, 
113). The globular head of MA positions a number of basic amino acids on one surface 
resulting in a basic patch that is oriented towards the PM. This basic patch interacts 
electrostatically with the positively charged inner leaflet of the PM. Most genera of 
retrovirus have a basic patch, with the net surface charge of MA domains differing from 
neutral to positive three or six, as in the case of equine infectious anemia virus (EIAV), 
RSV, and HIV-1, respectively (113).  
The inner leaflet of cellular plasma membranes is negatively charged owing to 
twenty to thirty molar percent of the net negative lipid phosphatidylserine (PS). The 
negative charge is increased by minor (1-2%) levels of the highly negative lipid 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2). In addition to phospholipids the 
plasma membrane contains high levels of cholesterol, neutral lipids, and by mass is 
roughly 50% cellular proteins (55).  
RSV MA binding to membranes 
The MA domain of RSV Gag is not myristoylated and does not appear to have a 
phosphatidylinositol-phosphate (PIP) binding pocket but instead likely relies on 
electrostatics to maintain protein-membrane interactions. Single and double mutations 
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of basic to acidic amino acids in RSV MA result in a decrease or a loss, respectively, of 
Gag localization to the PM and virion release (37). In the background of a double basic 
to acidic mutant, mutations elsewhere in MA that return the net surface charge to 
positive three restore virion release (37). Interestingly, mutating two acidic amino acids 
to basic amino acids, results in increased viral release (37). This mutant Gag protein, 
dubbed super-M or super membrane binder (SM), does not traffic through the nucleus of 
the cell, packages 1/10th the vgRNA of wild type (wt) particles, releases virus particles 
more rapidly than wt, and is non-infectious (36). It remains unclear if the decrease in 
vgRNA packaging is due to the rapid viral release or to the defect in nuclear trafficking 
(36). 
One of the most common ways used to study RSV MA and Gag membrane 
binding in vitro is a liposome flotation assay. In a typical flotation the protein of interest 
is mixed with liposomes, which are lipid membrane bilayers that may be uni- or multi-
lamellar depending on the method of preparation. The liposome-protein mix is subjected 
to sucrose equilibrium sedimentation, and any protein bound to a liposome will float to 
the top of the sucrose gradient owing to the low density of the liposome compared to the 
sucrose. By taking fractions of the gradient following flotation one can determine the 
percent of the total protein associated with liposomes by SDS PAGE analysis.  
Liposome flotation analysis of RSV MA and Gag strengthens the hypothesis that 
its membrane binding is driven by electrostatics. RSV MA binding to liposomes 
composed of physiological amounts of the negatively charged phospholipid PS 
decreases to undetectable levels as salt is increased from 75 to 500mM NaCl (59). A 
	   	   18	  
	  
	  
	  
MA mutant with two basic lysine residues mutated to the neutral asparagine is 
significantly defective in membrane binding (59). Increasing the lipid concentration of PS 
increases the amount of protein that associates with liposomes (45, 59). While some 
retroviral MAs bind specifically to PIPs, RSV MA has no known PIP binding pocket. 
However, RSV MA responds strongly to the presence of PIPs as measured by liposome 
flotation (chapter 4). This apparent discrepancy may be due to the high charge density 
of PIPs at physiological pH.  
It is difficult to disrupt the overall electrostatic charge of the inner leaflet of the PM 
without the possibility of generating experimental artifacts. However, it is possible to 
deplete the highly charged lipid, PI(4,5)P2 from the PM. If RSV Gag is dependent on 
PI(4,5)P2 for specific interactions, or for its charge, it is possible to detect this in vivo by 
PIP depletion. PI(4,5)P2 depletion from the PM is accomplished by overexpression of 
the polyphosphoinositide 5-phosphatase IV (5PtaseIV) protein. Depletion is observed 
indirectly by the relocalization of a PI(4,5)P2-specific binding protein domain from 
phospholipase-C, the pleckstrin homology domain, fused to the green fluorescent 
protein (PH-GFP) (45, 162). PH binding to PI(4,5)P2 is mediated by a basic patch 
oriented by three variable loops (14, 79, 99). In vivo, PI(4,5)P2 depletion does not cause 
a change in RSV Gag membrane association, as detected by GFP labeled Gag, or a 
change in the amount of virus particle release (45). Under equivalent conditions, HIV-1 
Gag does respond to PI(4,5)P2 depletion (45). However, under different conditions, 
RSV Gag shows slight sensitivity to PI(4,5)P2 depletion (114). Based on the conflicting 
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in vivo results it is difficult to assign a role to PI(4,5)P2 in RSV Gag membrane 
association.  
HTLV-1 and MLV MA binding to membranes 
Like RSV MA, HTLV-1 MA has no known PIP binding pocket, and PIP depletion 
in cells does not significantly alter Gag localization or virus release (92). HTLV-1 also 
does not respond to the presence of PI(4,5)P2 in liposomes but does respond to 
increased PS concentrations (92). The authors propose that HTLV-1 MA membrane 
binding is electrostatic, similar to RSV MA (92). RNase-mediated degradation of RNA 
from the liposome binding reaction does not increase HTLV-1 Gag binding to liposomes, 
similar to what is reported here in this thesis for RSV Gag (92). 
The MA domain of MLV Gag, similar to the MA domains of RSV and HIV Gag, 
has many clustered basic residues oriented so that they can interact with the PM. In 
vivo, virus production of MLV is significantly decreased by 5PtaseIV mediated depletion 
of PI(4,5)P2, despite there being no known MA PIP binding pocket (84). In vitro, MLV 
MA membrane binding is enhanced when the membrane contains any of the PIPs 
tested, but membranes containing PI(4,5)P2 enhances binding the most. Interestingly, 
the strong response to PI(4,5)P2 is not observed if the membrane does not contain PS 
(84). These results are difficult to interpret since the in vitro work was performed with a 
non-myristoylated purified MA protein, and myristoylation is known to be essential for 
MLV Gag function in vivo.  
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HIV-1 MA binding to membranes 
If RSV MA represents a simple model of membrane binding then HIV-1 MA could 
be placed at the opposite end of the spectrum. Also, because of the link of HIV-1 to 
human health, much more effort has been made to characterize it compared to the 
simpler virus RSV. HIV-1 MA contains as many as four membrane binding signals: a 
highly basic patch, a PIP binding pocket, an N-terminal fatty acid modification, and 
hydrophobic grooves that have been reported to bind to lipid acyl-chains (113, 138, 141, 
155) (Fig. 1.3). The highly basic patch is composed of multiple lysine and arginine 
residues in the front half of MA. These residues result in a plus six charge (compared to 
RSVʼs plus three). The first thirty-one residues of MA can function independently as a 
membrane-binding region, dependent on the basic residues and the myristate, as 
demonstrated by the membrane binding of a MA-Src chimera (166).  
Increasing the number of basic residues in HIV-1 MA increases membrane 
binding. For example, mutation I18K/L20K results in nearly double the amount of 
membrane-associated Gag protein compared to wt as measured by liposome flotation 
(123). The mutation K29T/K31T results in a three-fold reduction of virus release and 
K29E/K31E results in Gag accumulation at the Golgi in cells (73, 123). Individual 
mutation of the basic residues K18, R20, and R22 each results in a dramatic decrease 
in viral infectivity. However, these mutants still produce virions but with lower levels of 
Env incorporation, which may account for the decreased infectivity (22). Interestingly, 
mutations K29T/K31T and K29E/K31E do not significantly reduce binding to 
phosphatidylcholine/PS (PC/PS) membranes in a standard liposome flotation assay, but  
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Fig 1.3  HIV-1 MA binding to C8-PI(4,5)P2 (adapted from (141)). Structure of the N-
terminus membrane-binding domain colored according to electrostatic surface potential 
with basic areas in blue and acidic areas in red. The PI(4,5)P2 headgroup is shown with 
acidic phosphate groups in red and the 2ʼ lipid acyl chain, in grey, sequestered into a 
hydrophobic groove. 
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they decrease binding to membranes that contain PI(4,5)P2 (51). Taken together, these 
results show that electrostatics are a key driving force in HIV-1 Gagʼs interaction with 
membranes. 
Mass spectrometric protein footprinting found that of the twenty one modifiable 
lysines in Gag, only K29 and K31 (published as K30 and K32 due to a difference in 
annotation) bound well to PI(4,5)P2 (147). This indicates that some of the basic 
residues in HIV MA are positioned to respond specifically to PIP and are not required for 
electrostatic interactions.  
The binding of HIV MA to the phospholipid PI(4,5)P2 has been confirmed by 
multiple lines of investigation including NMR solution structure, in vivo depletion of PIP2, 
in vitro liposome binding assays, and the previously mentioned mutagenic studies. X-ray 
crystal structures of HIV-1 MA reveal a pocket that by NMR studies binds to PIPs. NMR 
solution structures show that HIV MA binds to the PIP headgroup of a soluble short 
chain PI(4,5)P2 but not to closely related phosphatidylinositol-3-phosphate (PI(3)P), 
phosphatidylinositol-4-phosphate (PI(4)P), or phosphatidylinositol-5-phosphate (PI(5)P) 
(141). Surprisingly, the NMR structure revealed that not only does the PIP head group 
bind to MA, but also the lipidʼs sn-2 acyl chain binds to a hydrophobic pocket on MA 
(Fig. 1.3). Cellular PIP acyl chains vary in length and saturation. Generally speaking, the 
sn-2 acyl chain is highly unsaturated, containing as many as four double bonds, which 
results in a high degree of chain disorder. It is possible that this chain samples the head 
group region of the bilayer and under the right conditions “pops-out” of the bilayer and, if 
MA is present, into MAʼs hydrophobic groove. This model is supported by a second 
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NMR study in which two additional hydrophobic grooves in MA were identified and 
shown to be capable of binding the sn-2 chain of PS, PC, or phosphatidylethanolamine 
(PE) lipids (155). A role for acyl chain involvement in MA binding to membranes is 
suggested by the results of a surface plasmon resonance study that found that the 
contribution of the lipid acyl chain provides more energy for binding to MA than the PIP 
head group (6). But because NMR studies of HIV-1 MA binding to lipid acyl chains have 
been performed with short-chain, soluble PIPs, it remains unclear if the binding is 
biologically relevant. 
 Liposome flotation assays of HIV Gag and purified HIV MA also show that PIPs 
strongly enhance binding of the proteins to liposomes (45, 51, 62). However, the 
enhancement of binding is not limited to PI(4,5)P2. PI(4)P, PI(3)P, and 
phosphatidyinositiol-3,4,5-phosphate (PI(3,4,5)P3) also enhance membrane binding of 
HIV Gag and RSV Gag, suggesting that the electrostatic affects of PI(4,5)P2 may not be 
easily separated from specific head group recognition. Surprisingly, 
phosphatidylinositol-3,5-phosphate (PI(3,5)P2) only weakly enhances the binding of 
RSV or HIV Gag to membranes in vitro (45, 51).  
HIV-1 Gag clearly shows sensitivity to PI(4,5)P2 in vitro, similar to RSV Gag, but 
is it sensitive to PI(4,5)P2 in vivo? Co-expression of 5PtaseIV with HIV-1 Gag, tested in 
multiple cell types, results in both a loss of Gag localization to the PM and loss of virus 
release (51, 92, 121). 
 A model of HIV-1 MA binding to membranes has emerged based largely on NMR 
data (139-141, 153, 155) and reviewed in (81) (Fig. 1.4). In this model, not only does 
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MA bind to PIPs but this binding also promotes structural changes in MA that increase 
myristate exposure. Also by NMR, purified MA is in a monomer-trimer equilibrium and 
trimerization causes structural changes that expose the myristate, perhaps increasing 
its insertion into a membrane (137, 153). Another line of investigation that fits the MA-
trimerization model comes from the Barklis lab, which showed that MA-CA forms 
hexamers of trimers on a supported bilayer containing PIP2 (2). 
In addition to HIV-1, HIV-2, EIAV, and Mason-Pfizer monkey virus (MPMV) also 
have PIP binding pockets (70, 132, 139). Unlike HIV-1, HIV-2 (139) and MPMV (132) 
binding to PIP2 does not promote myristate exposure. EIAV Gag responds to decreased 
levels of PIP in cellular membranes when a broadly acting phosphatase, synaptojanin-2,  
is expressed (70). By NMR EIAV binds more tightly to PI(3)P than to PI(4,5)P2 and in 
cells Gag is localized to cellular compartments enriched in PI(3)P in addition to 
localization to the PM (70). 
Another membrane binding signal found in nearly all retroviruses is 
myristoylation, an N-terminal post-translational modification that strengthens 
interactions with membranes. Most retroviral MAs are myristoylated, except RSV and 
EIAV (138). Addition of myristic acid, a fourteen-carbon fatty acid, occurs at a glycine 
residue located at the second amino acid position, i.e. following the initiating methionine. 
Myristoylation of HIV-1 MA is critical to MAʼs ability to bind to membranes. Mutation of 
glycine to alanine, which abolishes myristoylation, results in a loss of Gag localization to 
the PM and loss of virus release (118). In vitro, abrogation of myristoylation results in a 
significant decrease in Gag and MA binding to liposomes (51, 53, 60). Myristoylation is  
	   	   25	  
	  
	  
	  
Fig 1.4  HIV-1 MA trimer model of membrane binding (adapted from (71)) . 
This model shows how trimerized-MA binds to the bilayer and extracts the 2ʼ acyl 
chain of PI(4,5)P2 lipids. PIP is shown in yellow and myristic acid is shown in 
green.  	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arguably the most important membrane-binding signal as evidenced by a study in which 
the basic region of MA was deleted, including the PIP binding pocket (134). The only 
remaining membrane binding signal was the myristate, which was sufficient to localize 
Gag to the PM, and only modest reductions in viral particle production were measured 
(25, 134). Non-myristoylated Gag is dominant negative when co-expressed with wt Gag. 
This result may be partially dependent on NC mediated Gag-Gag dimerization (95).  
Clearly the binding of retroviral Gag proteins to the PM represents a complex 
interaction. HIV-1 Gag is arguably more complex than RSV Gag. By studying both viral 
Gag proteins, and making comparisons of them, we can better interpret results. For 
example, the finding that RSV Gag, which has no known PIP binding pocket, responds 
to PIPs in vitro but not in vivo calls into question the original interpretation of HIV-1 Gag 
binding to PIPs. Instead of a strong specific interaction between HIV-1 MA and the PIP 
head group, perhaps the stimulatory effect of PIPs on MA membrane-binding has more 
to do with electrostatic interactions.  
A role for nucleic acid in Gag membrane binding? 
The study of HIV MA membrane binding is complicated by the observation that 
HIV-1 MA also binds to nucleic acid. The nucleic acid binding has been proposed to be 
a regulatory mechanism that restricts MA from binding promiscuously to cellular 
membranes other than the PM (53). Flotations performed on Gag translated in rabbit 
reticulocyte reactions have the advantage of containing physiological concentrations of 
protein and nucleic acid. Following translation, RNA can be depleted from the 
reticulocyte reaction by treatment with RNase. This results in increased Gag membrane 
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interactions (52, 53). It should be noted that these binding experiments were performed 
at ionic strengths approximately 1/3 to 1/5 of physiological.  The effect of RNA on MA 
binding is not dependent on the presence of the highly basic NC domain and occurs for 
both reticulocyte translated and purified MA (data from chapter 4 and (52, 53)). In an 
alternative approach, to test the effect of PIP and nucleic acid on membrane binding, 
Barklis et al. bound purified MA to agarose beads and tested the affinity of the MA-
coated beads to liposomes containing trace amounts of fluorescently labeled lipids (4). 
In this assay, liposomes containing PI(4,5)P2 were able to outcompete nucleic acid for 
MA binding but liposomes without PI(4,5)P2 were unable to do so (4). In summary, 
while nucleic acid does bind to MA under certain conditions, this binding has not been 
shown to be biologically relevant.  
TRAFFICKING OF GAG TO THE PLASMA MEMBRANE 
 In principle there are two ways that Gag can reach the site of viral particle 
assembly, the PM, by diffusion or by a directed pathway. One hypothesis that has 
gained some traction suggests that Gag uses parts of the endosomal trafficking 
pathway to reach the PM. Multiple lines of evidence support this model for HIV-1 Gag 
trafficking (reviewed in (119)). Gag interacts with adapter complexes AP1, AP2, and 
AP3. Each complex plays a role in cellular transport between membrane compartments. 
Knockdown of AP1, which is involved in the transport of endosomes to the Golgi, results 
in a decrease in viral budding for both MLV and HIV-1, while overexpression of the AP1 
complex enhances release of HIV-1 Gag (42). AP2, which is involved in endocytosis, 
interacts with the MA domain of HIV-1 Gag and may act to restrict viral egress to Env 
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containing PM microdomains (12). The AP3 complex, which is involved in trafficking 
from early endosomes to late endosomes, has also been reported to interact with the 
MA domain of HIV Gag. Disruption of the interaction between HIV-1 Gag and AP3 
results in a decrease in particle production (66). However, NMR results suggest that 
AP3 may not interact directly with HIV MA (97).  
Env trafficking to the PM also involves endosomal trafficking. Env mainly resides 
in the trans-Golgi network (TGN) and interacts directly with an endosome-to-TGN 
transporter, TIP47 (24). TIP47 also interacts with the MA domain of HIV-1 Gag which 
would suggest that TIP47 acts as an adaptor between Gag and Env (106). Depletion of 
TIP47 abolishes Env incorporation into virus particles (13, 106). However, published 
reports of TIP47 are not all consistent. Checkley et al found that while MA does interact 
with TIP47, as measured by NMR, TIP47 overexpression or depletion in Jurkat T and 
HeLa cells does not affect incorporation of Env into virions (47). Based on these studies, 
it seems likely that TIP47 plays a role in the incorporation of Env into virus particles, but 
this function may be cell-type dependent. 
 Another example of Gag trafficking comes from studies that show that RSV Gag 
is trafficked into the nucleus, owing to two nuclear localization signals (NLS) located in 
the MA and NC domains, which bind to import receptors importin-11 and importin-alpha, 
respectively (35, 83, 144). Gag is exported out of the nucleus through the CRM1 nuclear 
export pathway by a nuclear export signal located in the p10 region (144, 145). What 
does Gag do while it is in the nucleus? When RSV Gag is mutated so that it is 
myristoylated, it bypasses trafficking through the nucleus resulting in decreased levels 
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of vgRNA packaging (78). This observation has led to the hypothesis that nuclear 
transport of RSV Gag is related to packaging. However, when RSV MA is replaced with 
the MA of HIV-1 Gag, cycling through the nucleus is lost but at least some viral 
infectivity is maintained (7). It remains unclear what role nuclear trafficking of RSV Gag 
may play. 
 
GAG MULTIMERIZATION 
 The formation of the retroviral Gag lattice likely begins with one or multiple Gag 
dimerization events. Gag dimerization is critical to viral particle formation and requires 
interactions between NC and nucleic acid. In vitro assembly of RSV virus-like particles 
(VLPs) requires nucleic acid long enough to support the binding of at least two Gag 
proteins (40, 108, 109). For HIV-1, the addition of nucleic acid and inositol phosphates 
(IPs) or PIPs is required to obtain regularly sized (VLPs) (38, 39). Abrogating the nucleic 
acid binding capacity of NC by mutation or deletion prevents in vitro and vivo assembly 
for RSV (93) but only modestly reduces virus particle production in vivo for HIV-1 (118, 
125). However, if NC is swapped for a naturally dimerizing leucine zipper, VLP 
formation is similar to that of wt Gag (56, 93). Chemical or oxidation-induced 
dimerization of Gag, whose NC domain is replaced with cysteines, also supports VLP 
formation (3).  
Does Gag multimerization occur prior to PM binding or do Gag monomers bind to 
the PM and than begin to multimerize? Because HIV-1 MA is in a monomer-trimer 
equilibrium, determined by NMR (153), it is possible to study the effect of MA 
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multimerization in cells without complicating results by using Gag. It should be noted 
that trimeric MA has never been observed in the context of the full length Gag protein. 
One group found HIV-1 MA monomers, dimers, and trimers in the cytoplasm of cells 
and associated with the PM (150). However, other studies using monomeric or dimeric 
chimeras of MA, observed monomeric HIV-1 MA to be entirely cytoplasmic and dimeric 
MA to be partially localized to the plasma membrane (60). Differences between results 
may be attributed to cell type or levels of protein production. Monomeric HIV-1 Gag is 
found at intracellular membranes and the plasma membrane indicating that it can reach 
sites of assembly although not efficiently enough for assembly (68). In the cell 
cytoplasm, Gag is monomeric and dimeric owing to a dimer interface in CA (75). 
However, monomeric Gag is not found associated with the PM; only Gag multimers are 
found associated with the PM (96). In addition, Gag is associated with genomic RNA in 
the cytoplasm (96). According to Hogue et al., increasing the membrane binding affinity 
of MA relieves reduced viral particle production caused by deletion of NC (87). 
Collectively, the data can be interpreted to mean that there is cooperation between 
assembly, RNA binding by NC, and membrane binding by MA.  
 Because RSV Gag has no known dimerization interface like the one found in 
HIV-1 Gag, and is monomeric at concentrations consistent with cellular levels, it is 
difficult to test cellular localization of monomeric vs dimeric RSV Gag. However, 
prevention of RSV Gag assembly by disrupting nucleic acid binding results in a diffuse 
cytoplasmic localization (93). Additionally, RSV MA is cytoplasmic and nuclear due to a 
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NLS in MA (77, 78). The cellular localization of RSV MA multimers will be covered in 
detail in chapter four. 
 
LATE DOMAINS 
Enveloped virus particles derive their membrane from the host cell in which they 
are replicated. Retroviruses like RSV and HIV-1 bud from the site of particle assembly, 
the plasma membrane. Following assembly of Gag and incorporation of the vgRNA, the 
viral particle undergoes a scission event, which separates the virus from the host cell 
membrane (also referred to as fission). The process of fission requires multiple cellular 
proteins that are part of the endosomal-sorting complexes required for transport 
(ESCRT) pathway. The ESCRT proteinsʼ normal cellular function is the biogenesis of 
multivesicular bodies (MVB) and cellular abscission (23, 72, 90, 91).  
 Late domains in the Gag polyprotein recruit cellular proteins to assembly sites at 
the PM. There are three classes of late domains with the consensus sequences 
PS/TAP, PPXY, and LYPXnL. The viral late domain PTAP found in the p6 domain of 
HIV-1 Gag recruits the ESCRT-1 complex through interactions with TSG101 (23, 90). 
PS/TAP is encoded by many budding viruses other than HIV-1, including Ebola, HTLV 
and simian immunodeficiency virus (SIV) (26, 63, 110, 156). The PPXY late domain, 
encoded by RSV Gag in the p2B region, interacts with WW domains of the Nedd4 family 
of ubiquitin ligases (63). The third domain, LYPXnL, which RSV Gag codes for as a 
secondary domain five amino acids downstream of its PPXY domain, interacts with Alix 
(63, 74). 
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 Generally late domains recruit ESCRT-I and/or ESCRT-II complexes with the 
ultimate goal of recruiting the ESCRT-III complex (90, 91). ESCRT-III includes the 
CHMP proteins, which are key to membrane scission (91). Two pathways for ESCRT-III 
assembly at the virus bud-neck have been proposed: the first is ESCRT-1-dependent 
and the second is Alix-dependent (43) (Fig. 1.5). In the ESCRT-1 dependent scission, 
ESCRT-1 interacts with Gag and ESCRT-II, which interacts with ESCRT-III 
components. The Alix-dependent model eliminates ESCRT-I and –II with Alix interacting 
with Gag and ESCRT-III directly.  
 
BUDDING FROM MEMBRANE RAFTS 
 Membranes can form more than one liquid domain, often referred to as raft 
behavior. A membrane raft is typically composed of high Tm lipids and cholesterol. This 
domain is more ordered than the surrounding membrane. A hypothesis has emerged 
that suggests that the Gag proteins select the plasma membrane to assemble and bud 
by binding to rafts. Two lines of investigation suggest that viral particles bud from lipid 
rafts.  First, multiple studies have found that the viral envelope has a lipid composition 
different than the bulk plasma membrane. While the studies do differ in degree and type 
of lipid enrichment, they generally find that in HIV-1 virus particles, cholesterol, 
ceramide, GM3, PIPs, PS, and plasmalogen-PE (pl-PE) are enriched (5, 32, 46, 126). 
However, the most recent of these studies found that virions have roughly two fold more 
pl-PE, PS, and sphingomyelin (SM) than the PM but found no enrichment of cholesterol 
(107). It should be noted that cholesterol is a critical component of raft formation (or  
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Fig 1.5  ESCRT-1 dependent and independent models of virion fission (adapted 
from (43)). Rod-like Gag proteins form an incomplete lattice in the forming virion. A 
subset of Gag interacts with either ESCRT-1 (panel 1) or ALIX (panel 2) to form the 
CHMP complex required for completing fission of the bud neck. 
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membrane phase behavior). Comparison of these studies reveals a range of cholesterol 
enrichment, from none to two-fold. Inconsistencies between studies may be due to 
variations in the methods used to measure cholesterol concentrations, techniques used 
to isolate the PM fraction from the cell, or the cell type used. In summary, these studies 
strongly suggest that the viral envelope has a lipid composition that differs from the bulk 
PM. 
 Depletion of cholesterol from the plasma membrane of cells transfected with HIV-
1 Gag by methyl-β-cyclodextrin (MβCD) results in a reduction of Gag membrane binding 
and a reduction of higher order Gag multimerization (124). Cholesterol depletion also 
decreases viral budding of other enveloped viruses such as influenza (10) and West 
Nile virus (111). Cholesterol also enhances membrane binding of Gag in vitro (62).  
Not only is cholesterol enriched in, but also it is an essential component of, the 
virus particle envelope. Removal of cholesterol from the viral envelope decreases 
infectivity of enveloped arboviruses (149) and influenza virus (152). Cholesterol may 
play an important role in maintaining the integrity of the viral enveloped core as 
evidenced in a study with HIV-1 and SIV that found cholesterol depletion resulted in 
abrogation of enzymatic properties of IN and RT (82). Viral infectivity can be restored by 
adding cholesterol back into the membrane of virus particles (41). However, EM 
analysis of cholesterol-depleted virions revealed that their membranes had holes (82) so 
it is possible that cholesterol depletion wrecks the viral membrane. 
Cellular cholesterol is also important for virus entry into cells. For example, HIV-1 
virions bind well to the surface of cholesterol depleted macrophage cells but their entry 
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is blocked (44). Taken together these results clearly show that cholesterol is a critical 
component of viral budding and entry.  
Since cholesterol is one major component of lipid rafts it has become common to 
cite these studies as evidence that lipid rafts are important for viral function. This 
hypothesis is further supported by the observation that HIV-1 Gag is found in detergent 
resistant membrane (DRM) fractions, and this localization is dependent on Gag 
multimerization (104). DRMs are membrane fractions that are enriched in cholesterol 
and sphingolipids, and are often identified as evidence for the presence of membrane 
rafts in the cellular PM. However, the process of DRM isolation may induce lipid 
segregation. Interestingly, fatty acid modification of Gag with unsaturated myristic acid 
analogs decreases Gagʼs localization to the DRM membrane fraction, and blocks 
budding (104, 105).  
Other evidence for a role of lipid rafts in viral budding comes from studies that 
show that sites of Gag assembly co-localize with proteins found in DRMs, and DRM-
proteins are found in budded virus particles (reviewed in (88, 119, 122)). Virions 
collected from T-cells contain GPI-linked proteins Thy-1 and CD59 which are known to 
partition to DRM fractions (115). HIV-1 Gag also co-localizes with these DRM proteins in 
the uropods of T-cells (115). Interestingly, sites of Gag assembly do not contain proteins 
that are not found in DRM fractions (115).  
In addition to the inclusion of DRM proteins into viral particles, HIV-1 Gag co-
localizes with tetraspanin enriched microdomains (TEMs) at the PM, and TEMs have 
been found in virions (120). TEMs contain short, transmembrane proteins that have four 
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membrane spanning sequences, and are one of many membrane structures that inhibit 
random mixing of membrane proteins and lipids (117, 163). Virion-associated TEMs 
modulate infectivity by inhibiting Env mediated fusion with cells (143). TEMs also act to 
inhibit Env-induced cell-cell fusion which interestingly requires the presence of Gag 
(157). 
 Based on mounting evidence, it seems clear that viral budding from cells is a 
tightly controlled process that includes selection of specific lipid types and the 
incorporation of non-randomly distributed proteins. Cellular protein incorporation may 
occur because Gag assembly occurs at sites enriched in the proteins or because Gag 
induces the formation of a membrane domain to which these proteins preferentially 
distribute. Alternatively, studies of TEMs suggest that the cell may act to restrict viral 
entry by incorporating specific membrane proteins into the viral envelope (157). 
Whether the presence of cholesterol or increased levels of pl-PE represent the 
formation of or recognition of a raft by the virus, or if these lipids are enriched due to 
virion-induced curvature, needs to be resolved.  
While extensive work has been done to characterize raft behavior for biologically 
relevant lipid mixtures, no raft behavior has been observed for mixtures that mimic the 
inner leaflet of the plasma membrane. It is possible that raft behavior on the outer leaflet 
of the bilayer is transmitted to the inner leaflet through the interdigitation of the lipid acyl 
chains but this has yet to be determined. Clearly current models do not satisfy the 
existing data and so further work is required to develop a more complete picture of Gag 
binding to and budding from the PM. 
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LIPIDS AND MEMBRANES 
To better understand the role lipids play in Gag membrane interactions and the 
formation of the viral envelope it is necessary to have an understanding of lipid 
behavior. Lipids represent a diverse group of molecules involved in energy storage, 
signaling, and the structure of cellular membranes. Glycerophospholipids, characterized 
by a glycerol head group and two fatty acid chains, represent the predominant group of 
polar membrane lipids in eukaryotic cells (154) (Fig. 1.6). The most common cellular 
glycerophospholipids are PC, PS, PE, phosphatidylinositol (PI), and phosphatidic acid 
(PA). The sterol cholesterol is the most common non-polar membrane lipid.  
The plasma membrane of cells is an asymmetric bilayer approximately 30 
Angstroms thick and represents only 2-3 percent of total cellular lipids (1). 
Approximately 50% of the plasma membrane mass is protein, so the study of retroviral 
protein interaction with membranes prepared from pure lipids must be considered 
incomplete. However, in vitro characterization of lipid mixtures has yielded many 
breakthroughs in the understanding of membranes and so these studies are useful. 
Lipids can be characterized by a number of measurements including their rate of 
lateral diffusion (translational diffusion coefficient (DΤ)) and the order, or degree of 
movement, of their segmented acyl chains (S). Defining the characteristics of lipids in a 
membrane bilayer can also be thought of as defining the phase behavior of the 
membrane bilayer. Membrane phase behavior refers to the solid or liquid state of 
individual lipids and mixtures, and how this state changes as temperature changes  
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Fig 1.6  Key lipid characteristics. A) Some common lipid head groups shown without 
hydrogen atoms. The smallest PE is enriched on the inner leaflet of the PM with the net 
negative PS and PI(4,5)P2 lipids. PC is found primarily on the outer leaflet of the PM. B) 
Cholesterol and lipid acyl chains occupy the hydrophobic core of the membrane bilayer. 
Lipid acyl chains can be saturated (no double bonds) as pictured for the chain in the sn-
1 position, or unsaturated as pictured for the chain in the sn-2 position. C) The order 
parameter of a segmented acyl chain (S) is a measure of the space the lipid sweeps out 
(ΔΘ).  
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(154). Membrane phases include liquid-disordered (Ld), liquid-ordered (Lo), and solid-gel 
(Lβ) (Fig. 1.7). Liquid-disordered lipid bilayers generally have low concentrations or no 
cholesterol and lipids with unsaturated acyl chains (154). The lipids are loosely packed 
with their chains sampling a large cone of space below the lipidʼs head group. The 
space the acyl chain samples is ΔΘ. Due to the packing density of lipids the Ld bilayer is 
thin. Solid-gel bilayers are composed of lipids that pack closely to each other with a low 
ΔΘ (154). Additionally, the rate that lipids exchange with each other in the solid-gel 
bilayer is about a thousand-times slower than in liquid-disordered bilayers. Liquid-
ordered bilayers typically contain a mix of saturated and unsaturated acyl chain lipids 
and cholesterol, and while the bilayer has a ΔΘ similar to solid-gel its DΤ is similar to 
liquid disordered (154).  
Similar to lipid acyl chains, cholesterol must be shielded from the aqueous 
environment, but unlike lipids cholesterol does not contain a hydrophilic head group. 
Shielding of cholesterol in the bilayer is accomplished by straightening of lipid acyl 
chains (a decrease in ΔΘ) so the lipid head group can shield both its own acyl chains 
and cholesterol (89). 
Membrane phase behavior can be determined for up to three and four 
component lipid mixtures. These data can be displayed in a phase diagram. A typical 
three-component phase diagram displays the membrane phase behavior for mixtures of 
cholesterol, a high Tm (saturated) lipid, and a low Tm (unsaturated) lipid (Fig. 1.8). 
These diagrams can be used to determine if a given mixture is one, two, or three phase,  
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Fig 1.7  Membrane phase behavior (Figure adapted from (154)). Three phases, liquid-
disordered, solid gel, and liquid-ordered are pictured from top to bottom. Phases are 
defined by the order of the order parameter of the segmented acyl chains (low S when 
the chains have a high ΔΘ, and high S when the chains have a low ΔΘ). The rate of the 
average lipid latter diffusion DT is fast for liquid-disordered and liquid-ordered 
membranes, but slow for solid gel membranes.
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Fig 1.8  Three component phase diagram. The vertices of the triangle represent pure 
components: 100% cholesterol, 100% low Tm lipid, and 100% high Tm lipid. Each side 
of the triangle represents a binary mixture. This particular phase diagram displays a 
two-phase coexistence region, Ld+Lo, surrounded by one-phase regions Ld or Lo, and 
a three-phase coexistence region (unlabeled) below. To read a composition, choose 
any point within the triangle, e.g. point “A”. From point “A”, draw three lines towards 
each binary axis that are parallel to each sides of the triangle. The mole % of each 
component for “A” is read directly from where the lines intersect with the binary axes. In 
this example, the composition is 40% high Tm lipid, 20% low Tm lipid, and 40% 
cholesterol. 
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and if those phases are Lo, Ld, or Lβ. Phase diagrams also define the composition of 
mixtures that are near critical points between two phase and one-phase mixtures. 
Membrane phases can be nanoscopic or microscopic. Nanoscopic domains are 
typically characterized using Förster resonance energy transfer (FRET) while 
macroscopic domains can be observed with a microscope by employing giant 
unilamellar vesicles (GUVs) prepared with fluorescent dyes that partition into different 
phases (85). FRET also measures the partitioning of lipid dyes in bilayers (33). An 
advantage of FRET is that preparation of the membranes by rapid solvent exchange 
(RSE) does not require lipids to transition through a dry phase, a step that is required in 
GUV preparation that may introduce artifacts (34).  The use of GUVs to study  
membrane phase behavior yields striking and convincing evidence for the presence of 
lipid phases. 
Formation of distinct membrane phases has never been observed in living or 
fixed cells. This does not mean that it does not occur. The phases may be nanoscopic 
and so not observable by microscopic techniques. There is indirect evidence for the 
existence of phase behavior in cellular membranes. For example, treating cells with cold 
detergent results in the isolation of a highly ordered, raft-like lipid and protein fraction 
dubbed detergent resistant membranes (DRMs). DRMs are enriched in cholesterol and 
sphingolipids (31, 148) and one study found enrichment of arachidonic acid (20:4) and 
PE (128). Electron spin resonance (ESR), a method that measures the order of lipid 
bilayers, found that DRMs isolated from rat peripheral blood cells (RBL-2H3) were liquid 
ordered (80). While the behavior of DRMs has convincingly been defined as raft-like, it 
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remains unclear if DRMs represent a phase present in living cells or an artifact 
generated during cold detergent treatment of cells. 
Further evidence for cell membrane phase behavior comes from microscopic 
based studies that characterize GUV-like membranes isolated from the PM of cells. The 
first study collected giant plasma membrane derived vesicles (GPMV) from cells by 
treating them with paraformaldehyde which induces membrane blebbing (15). At room 
temperature GPMVs demonstrate lipid dye partitioning similar to that observed for 
model membranes with well defined Lo and Ld phases (15). The second study collected 
GUVs by the paraformaldehyde method and an alternative method which involves the 
swelling of cell membrane spheres (CMS) with PBS buffer (94). The CMSs 
demonstrated phase separation similar to GPMVs, and the inclusion of a PM protein, 
the transmembrane protein linker for activation of T cells (LAT) in the Lo phase was also 
detected (94). Perhaps owing to the inclusion of the LAT transmembrane protein, the Lo 
phase of CMSs is significantly less ordered than that of model membrane mixes (94). 
This is an important observation given that cellular membranes contain equivalent 
amounts of lipids and proteins. If rafts are present in cellular membranes it is likely that 
they are associated with or perhaps induced by membrane associated cellular proteins 
(133). 
While a role for PM phase behavior has not been identified for viral assembly and 
budding, as has previously been discussed, that does not mean that understanding 
membrane behavior is not important to understanding Gag membrane binding. As will 
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be presented in Chapter 3, the presence of cholesterol and the types of lipid acyl chains 
in a membrane have dramatic effects on the interaction of Gag with a membrane. 
 
THESIS OUTLINE 
 The binding of the retroviral Gag protein to the PM is a critical step in the virus life 
cycle. The signals that govern both components of this interaction, the membrane and 
the protein, are many. Characterizing the signals and how they overlap each other is 
difficult. While the field has made significant progress in this endeavour there are still 
gaps in our knowledge. In chapters 2, 3, and 4 I present my work to address some of 
these gaps. 
 Does the binding of RSV Gag to membranes require the presence of the lipid 
PI(4,5)P2? In chapter 2 I present data from a comparative study of RSV and HIV-1 Gag 
proteins and their sensitivity to PI(4,5)P2. I found that unlike HIV-1, RSV was not 
sensitive to PI(4,5)P2 depletion in cells. Interestingly, both RSV and HIV-1 Gag 
responded similarly to the presence of PI(4,5)P2 as measured by in vitro flotation. 
These results are interpreted to mean that the effect of PI(4,5)P2 may be at least in part 
due to its electrostatic contribution to the membrane and that this contribution may be 
difficult to untangle from the effect of specific recognition of the PIP head. 
 The observation that HIV-1 Gag responds strongly to increasing PS 
concentrations and the popular hypothesis that retroviruses bud from membrane rafts 
motivated me to address the effect of membrane order and PS on Gag binding. In 
chapter 3 I present data from a study of these two factors. I found that while increasing 
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concentrations of membrane PS does stimulate membrane binding, the effect was 
strongly influenced by the acyl chains of the PS lipid. I also determined that the 
presence of cholesterol in the membrane also increased Gag binding. However, both 
the effect of cholesterol and lipid acyl chains was independent of the overall order of the 
membrane. 
 It is known that Gag assembly occurs at the PM but it is not known what the role 
of Gag multimerization is on Gagʼs ability to bind the PM. In chapter 4 I present data 
from a study which addresses this gap in our understanding. One striking result from 
this study is the difference between the level of MA-multimerization required to localize 
RSV MA and HIV-1 MA to the PM in vivo. In addition to determining the effect of 
multimerization on binding of MA to membranes, I also studied the effect of RNA on 
inhibiting this interaction. I found that HIV-1 MA binding to membranes, at physiologic 
ionic conditions, is inhibited by RNA, but RSV MA is not. 
 While we have made advances in our understanding of Gag-membrane 
interactions there are still a great number of things we do not know. In chapter 5 I 
present some of the interesting questions remaining in this field and propose some 
methods that could be used to begin to answer them.   	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CHAPTER 2 
ROUS SARCOMA VIRUS GAG HAS NO SPECIFIC REQUIREMENT FOR 
PHOSPHATIDYLINOSITOL-(4,5)-BISPHOSPHATE FOR PLASMA 
MEMBRANE ASSOCIATION IN VIVO OR FOR LIPOSOME 
INTERACTION IN VITRO1 
 
            The MA domain of the retroviral Gag protein mediates interactions with the 
plasma membrane, which is the site of productive virus release.  HIV-1 MA has a 
phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2] binding pocket; depletion of this 
phospholipid from the plasma membrane compromises Gag membrane association and 
virus budding.  We used multiple methods to examine the possible role of PI(4,5)P2 in 
Gag-membrane interaction of the alpharetrovirus Rous sarcoma virus (RSV).  In 
contrast to HIV-1, which was tested in parallel, neither membrane localization of RSV 
Gag-GFP nor release of virus-like particles was affected by phosphatase-mediated 
depletion of PI(4,5)P2 in transfected avian cells.  In liposome flotation experiments, RSV 
Gag required acidic lipids for binding but showed no specificity for PI(4,5)P2.  Mono-, di- 
and tri-phosphorylated PIP species as well as high concentrations of phosphatidylserine 
(PS) supported similar levels of flotation.  A mutation that increases the2 overall charge 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  The following section is reproduced from: Chan, J., R. A. Dick, and V. M. Vogt. 2011. 
Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-
bisphosphate for plasma membrane association in vivo or for liposome interaction in 
vitro. J Virol 85:10851-60, with modifications to conform to the required format. R.A.D. 
perfomed liposome flotations and virus release. J.C. performed cell imaging. 	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of RSV MA also enhanced Gag membrane binding.  Contrary to previous reports, we 
found that high concentrations of PS, in the absence of PIPs, also strongly promoted 
HIV-1 Gag flotation.  Taken together, we interpret these results to mean that RSV Gag 
membrane association is driven by electrostatic interactions and not by any specific 
association with PI(4,5)P2. 
  
INTRODUCTION 
Assembly and budding of retrovirus particles are complex processes mediated by 
the viral structural protein Gag.  Several thousand Gag molecules along with two copies 
of the RNA genome and the viral glycoprotein Env are transported to the assembly site 
where Gag-lipid, Gag-Gag, and Gag-RNA interactions drive the formation of a virus 
particle.  The assembly site is determined largely by the membrane binding domain 
(MBD) at the N-terminus of the Gag protein, which mediates membrane targeting and 
membrane binding (25, 43, 58, 59, 64, 68).  For most retroviruses, productive viral 
assembly occurs at the plasma membrane (PM) (21, 30).   
Across retroviral genera, sequence similarity among retroviral MBDs is limited; 
however, all previously studied retroviral MBDs fold into a small, globular domain with 
an alpha helical core (40).  The MBD usually contains two membrane-binding signals, 
an N-terminal myristate, which inserts into the hydrophobic interior of lipid membranes, 
and a surface patch of basic residues, which interacts with acidic phospholipids.  
Several retroviral MBDs are not myristoylated , including those of equine infectious 
anemia virus (EIAV) (10, 26) and Rous sarcoma virus (RSV) (38). In contrast, the basic 
patch is highly conserved, suggesting that electrostatic interactions are universally 
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important in membrane binding of Gag (40).  Depending on the type of retrovirus and 
the severity of the changes, mutations in the basic patch can shift Gag localization from 
the plasma membrane to intracellular membranes (22, 43, 60), promote promiscuous 
binding to cellular membranes (55), or abolish membrane binding entirely (6, 58).  
Mutations that increase the positive charge of the basic patch can rescue Gag 
localization to the PM or enhance the release of virus particles (5, 6). 
Acidic phospholipids, especially phosphatidylserine (PS) and phosphatidylinositol 
phosphates (PIPs) are important cellular factors in mediating protein-membrane 
interactions (27, 35, 39, 67). PS has a single, net negative charge, while PIPs have 
multiple negative charges due to phosphorylation of the inositol ring at positions 3, 4 
and/or 5.  The location and degree of phosphorylation is determined by spatially 
regulated kinases and phosphatases, which results in the enrichment of specific species 
of PIPs at different cellular membranes [reviewed in (33)].  PS and PI(4,5)P2 are found 
primarily on the inner leaflet of the PM in mammalian cells, where they account for 25-
35% and 0.5-1.0% of the phospholipids, respectively (2, 9, 36, 49).  Recruitment of 
cellular MBDs [e.g. pleckstrin homology (PH) domains (16, 19, 63), C2 domains (37), 
and epsin N-terminal homology domains/AP180 N-terminal homology (ENTH/ANTH) 
domains (28)] to the PM is dependent on direct interactions with PS and/or PI(4,5)P2.  
However, the quantitative contribution of each of these acidic lipids to PM binding of 
proteins is uncertain since different studies have yielded conflicting results (27, 67). 
As purified proteins, some retroviral MBDs (e.g. that of HIV-1 and HIV-2) bind 
specifically to versions of PI(4,5)P2 that have shortened fatty acid chains required for 
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solubility (51, 54).  Mutation of the residues involved in PI(4,5)P2 interaction reduces PM 
affinity in vivo and also binding to artificial liposomes in vitro (3, 10, 25, 51, 54, 57).  
Consistent with the inferred role for this lipid in virus assembly at the PM, the membrane 
surrounding HIV-1 and murine leukemia virus (MLV) virions is enriched in PI(4,5)P2 (9) 
as well as PS (2, 4, 47).  Furthermore, over-expression of inositol polyphosphate-5-
phosphatase E (here referred to as 5ptase), which depletes cellular levels of PI(4,5)P2 
(32), results in a decrease in Gag localization at the PM and a reduction in virus release 
(25, 42, 51, 60).  In the case of HIV-1, binding to PI(4,5)P2  leads to exposure of the 
myristate, thereby enhancing the affinity of the MBD for the PM (53, 54). 
The RSV MBD is not myristoylated, nor does it contain a linear sequence of basic 
residues as do EIAV and MLV.  However, the three-dimensional structure of the protein 
reveals that multiple basic residues come together to form a surface patch (38).  The 
RSV MBD has a net positive charge of +5 (5).  Small deletions or neutralization of two 
or more basic residues in the surface patch abolish PM localization and reduce virus 
release (5, 6, 41, 44, 64). Compensatory mutations that restore the net positive charge 
of the MBD also restore PM localization, whereas some mutations that increase the 
overall charge alter the intracellular trafficking of RSV Gag, enhance Gag localization at 
the PM, and accelerate the budding kinetics of virus-like particles (VLPs) (6).  These 
results were interpreted to imply that RSV Gag-membrane binding is driven chiefly by 
electrostatic interactions (5, 6). 
Using computational modeling and liposome flotation assays with purified 
recombinant proteins, we previously reported that RSV and HIV-1 MA membrane 
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binding in vitro is driven by electrostatic interactions with negatively charged lipids (13, 
14).  Preliminary data also suggested that PI(4,5)P2 at 1% of total phospholipid does not 
significantly enhance MA-liposome binding in the presence of physiological levels of PS.  
We have now extended these studies to the RSV Gag protein, in comparison with the 
HIV-1 Gag protein that has been studied by others (1, 11, 12, 20, 29).  By fluorescence 
imaging and virus release in cells and by liposome flotation of protein synthesized in a 
reticulocyte lysate, RSV Gag appears to have no specific requirement for PI(4,5)P2 in 
membrane targeting and viral assembly in vivo or for liposome binding in vitro.  Rather, 
RSV Gag membrane association relies only on electrostatic interactions. 
 
MATERIALS AND METHODS 
DNA Vectors 
RSV and HIV Gag constructs used in this study are shown schematically in Fig. 
2.1.  All DNA constructs were generated with common subcloning techniques and were 
propagated in DH5α cells.  The 5ptase expression vector, pcDNA4TO/Myc5ptaseIV (11) 
was a gift from Akira Ono.  Plasmid PH-GFP, a gift from Barbara Baird, encodes the 
pleckstrin homology (PH) domain from human phospholipase C δ1 fused to eGFP 
under control of the cytomegalovirus immediate early promoter.  Fluorescent Gag 
proteins were created by cloning RSV GagΔPR derived from the Prague C strain or 
HIV-1 Gag derived from the BH-10 strain into the pEGFP-N1 vector (Clontech).  Plasmid 
PHGag-GFP was constructed by subcloning the PH domain from pPH-GFP into RSV 
GagΔPR-GFP between the SacI site (nt 255) in the leader region and the XhoI site in  
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Fig. 2.1  Schematic representations of proteins.  RSV and HIV-1 GFP-tagged 
proteins expressed in transfected cells are shown at the top along with the PH-GFP 
protein. Proteins translated in vitro and submitted to flotation analysis are shown at the 
bottom.  Vertical lines in the boxes stand for protease cleavage sites. 	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MA (nt 630), which has traditionally been used to define the C-terminal end of the RSV 
MBD (38).   
The previously described plasmid RSV GagΔPR (8) was used to generate 
SuperM (SM)GagΔPR and PHGagΔPR.  The RSV SMGag construct (6) was a gift from 
John Wills.  The region of MA containing the SM mutations E25K and E70K was PCR 
amplified and cloned into pET3xc RSV GagΔPR using sites XbaI (in the backbone of 
the vector and added upstream of Gag by PCR) and XhoI (nt 630).  RSV PHGagΔPR 
was constructed by PCR amplifying the PH domain from PH Gag-GFP and cloning the 
product into RSV GagΔPR using sites XbaI and XhoI.  The plasmid expressing HIV-1 
GagΔp6 (strain BH10) was a gift from Alan Rein.  For simplicity, in the Results and 
Discussion sections of this paper, RSV GagΔPR and its derivatives as well as HIV-1 
GagΔp6 are referred to as RSV Gag and HIV-1 Gag, respectively. Neither of these 
deleted domains affects the membrane targeting properties of Gag or the first steps in 
assembly. 
Cells and transfection  
Cell cultures and transfections were performed as previously described (14).  
DF1 (chicken) and QT6 (quail) fibroblast cells were maintained in Dulbecco modified 
Eagle medium supplemented with 5% fetal bovine serum, 5% NuSerum (BD 
Biosciences), 1% heat-inactivated chick serum, standard vitamins, L-glutamine, 
penicillin and streptomycin.   
DF1 and QT6 cells were seeded onto glass cover slips for imaging or six-well 
plates for virus release assays 24 h prior to transfection.  DF1 cells at 60% confluency 
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were transfected with 2 μg of total DNA at a 1:1 ratio of fluorescent Gag to the 5ptase 
expression plasmid or to the control plasmid pBluescript SK(+) (Stratagene).  QT6 cells 
at 30% confluency were transfected with 3 μg of total DNA at a 1:2 ratio of fluorescent 
Gag to 5ptase or control plasmid.  Transient transfections were performed using 
FuGENE HD (Roche) according to manufacturerʼs instructions.   
Virus release and immunoblotting 
Medium and cells were collected 24 h post-transfection.  The medium was 
centrifuged at 5,000 x g for 5 min to remove cellular debris.  Virus-like particles (VLPs) 
were isolated by layering the cleared medium onto 0.50 mL virus pelleting buffer (15% 
sucrose in 20 mM Tris HCl [pH 7.5], 100 mM NaCl, 1 mM EDTA) and centrifuging at 
90,000 rpm for 45 min in a Beckman TLA 100.4 rotor.  Western blots were performed on 
cellular and VLP-associated Gag using rabbit anti-RSV capsid (αCA) serum diluted 
1:1,000 or rabbit anti-HIV-1 p24 (NIH AIDS Research and Reference Reagent Program, 
Reagent 4250) diluted 1:5,000 and then probed with anti-rabbit IgG-Alkaline 
phosphatase (Sigma) diluted 1:30,000.  Following incubation in the ECF reagent 
(Sigma), blots were imaged on a Storm scanner (Molecular Dynamics).  Bands were 
quantified using Image Quant software. 
Liposome binding assay 
Liposomes were prepared as previously described with some modifications (13).  
The lipid concentrations were chosen largely based on previously published studies, to 
facilitate comparisons.  Chloroform solutions of purified natural L-α-phosphatidylcholine 
(egg PC), L-α-phosphatidylserine (brain PS), L-α-phosphatidylinositol-4,5-bisphosphate 
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(brain PI(4,5)P2), L-α-phosphatidylinositol-4-phosphate (brain PI(4)P), and dry 
unsaturated 1,2-dioleoyl-sn-glycero-3-phospho-(1ʼ-myo-inositol-3ʼ-phosphate) (18:1 
PI(3)P), 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',5'-bisphosphate) (18:1 
PI(3,5)P2), 1,2-dioleoyl-sn-glycero-3-phospho-(1'-myo-inositol-3',4',5'-trisphosphate) 
(18:1 PI(3,4,5)P3) were purchased from Avanti Polar Lipids.  Dry lipids were 
resuspended in chloroform per the manufacturerʼs directions.  Chloroform solutions of 
PC and PS (67%:33%, 50%:50%, or 33%:67%), or PC, PS, and PIPs 
(61.75%:31%:7.25%) were mixed at the stated ratios and then dried under a stream of 
nitrogen and resuspended (1 hr to overnight at 4°C with occasional mixing) in 20mM 
HEPES (pH 7.0) to a concentration of 10 mg/mL under nitrogen gas.  The resuspended 
lipids were passed at least 60 times through a 100 nm polycarbonate filter in an Avanti 
extruder to yield uniform liposomes.  Liposomes were stored at 4°C under nitrogen and 
used no later than 10 days after preparation.  
 In vitro translation and liposome binding reactions were performed as previously 
described with modifications (11).  Briefly, in vitro translation of the Gag constructs was 
performed using the T7 coupled TNT reticulocyte lysate system (Promega).  Fifty μL 
reticulocyte reactions were prepared according to the manufacturerʼs instructions with 
[35S]methionine-cysteine (Perkin Elmer: ExPRE35S35 protein labeling mix) for protein 
labeling and incubated for 90 min at 30°C.  Then 100 μg of liposomes was added to the 
reaction, for a final liposome concentration of 1.7 mg/mL, and incubated for an 
additional 30 min at 30°C. 
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 In preparation for flotation, the reticulocyte reaction with liposomes was diluted to 
a final volume of 0.25 mL with 20 mM HEPES (pH 7.0), mixed with 0.75 mL 67% 
sucrose, and then transferred to an ultracentrifuge tube.  The mixture was overlaid with 
1.6 mL 40% sucrose followed by 0.40 mL 4% sucrose.  All sucrose solutions were 
prepared by dissolving sucrose (wt/wt) in 20 mM HEPES pH 7.0.  The sucrose gradients 
were centrifuged at 90,000 rpm at 4°C for 180 min in a Beckman TLA 100.4 rotor.  Four 
0.75 mL fractions were collected.  The top one or two fractions represented liposome-
bound Gag, and the bottom two fractions represented non-liposome-bound Gag.  
Unless otherwise noted, 30 μL of each fraction was resolved by SDS PAGE.  The gels 
were incubated for 30 min in 1M sodium salicylate, dried, and placed on film at -80°C for 
16-36 hr.  The resulting autoradiograms were scanned and quantified using Image 
Quant software.   
Many attempts were made to resolve the persistent high molecular weight band 
observed on the fluorograms of RSV Gag (and derivatives of Gag) flotations with 
liposomes containing PIPs.  These included increasing the concentration of SDS in 
loading buffer, adding urea to 8M, incubating with NaOH, and varying the time, pH, and 
temperature of samples incubated prior to gel loading.  None of these treatments had a 
significant effect. 
Immunofluoresence and confocal microscopy 
Monoclonal anti-myc antibody (Covance) was diluted 1:1,000 in phosphate-
buffered saline (pH 7.4) (PBS).  Tetramethyl rhodamine isothiocyanate-conjugated anti-
mouse antibody was diluted 1:500 in PBS with 1% non-fat milk carrier.  DF1 and QT6 
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cells were collected 12-16h or 20-24h post-transfection, respectively, and fixed with 
3.7% formaldehyde in PBS for 15 min, permeabilized with 0.1% Tween 20 in PBS for 15 
min, and then blocked with 4% bovine serum albumin for 30 min.  Cells were stained 
with primary and secondary antibodies for 30 min each at 37°C, and then mounted on 
glass slides with Fluoro-Gel (Electron Microscopy Sciences) for viewing on an Ultraview 
spinning disc confocal microscope (Perkin-Elmer) with a Nikon 100x Plan-Apochromat 
oil objective lens (NA 1.4).  Image analysis and confocal stacks were generated with 
ImageJ software (v1.44d). 
 
RESULTS 
Effect of 5ptase over-expression on PI(4,5)P2 levels at the PM 
The enzyme 5ptase removes the phosphate at position 5 of the inositol ring on 
PIPs, converting PI(4, 5)P2 and PI(3,4,5)P3 to PI(4)P and PI(3,4)P2, respectively (32).  
Previous studies using human 5ptase or the yeast homolog (Inp54p) reported that over-
expression of this enzyme led to a significant decrease in PI(4,5)P2 levels at the PM (42, 
65).  We first sought to determine if human 5ptase had a similar effect on PI(4,5)P2 
levels in avian cells.  DF1 chicken fibroblasts and QT6 quail fibroblasts were co-
transfected with DNAs encoding 5ptase and the PH domain of human phospholipase C 
δ1 (PLCδ1) fused to GFP.  This well-studied PH domain binds to PI(4,5)P2 with high 
specificity and is commonly used as a reporter for the presence of PI(4,5)P2 in cells (16, 
19, 63).  Both cell types were initially imaged at 24h post-transfection, but DF1 cells 
proved to be highly sensitive to 5ptase-induced apoptosis, displaying extensive 
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vacuolation and blebbing at the PM (data not shown).   Therefore, DF1 cells were 
imaged at 12-16h post-transfection when the cells were still healthy.  QT6 cells were  
more resistant to the toxic effects of PI(4,5)P2 depletion, appearing normal after 24h, 
and consequently were imaged at 20-24h post-transfection.   
In the absence of 5ptase, PH-GFP localized primarily to the PM in both DF1 and 
QT6 cells (Fig. 2.2 top panels), especially to membrane ruffles and cellular protrusions 
expected to be enriched in PI(4,5)P2.  Co-transfection of the myc-tagged 5ptase 
abolished PM localization of PH-GFP in both cell types (Fig. 2.2 bottom panels), 
resulting in a diffuse signal throughout the cytoplasm.  Over-expression of 5ptase also 
led to a nuclear accumulation of PH-GFP.  PLCδ1 has been shown to shuttle between 
the cytoplasm and the nucleus (66), suggesting that PI(4,5)P2-dependent association 
with membranes competes with transport into the nucleus.  Our observations indicate 
that human 5ptase significantly depletes PI(4,5)P2 at the PM in these avian cell types.  
PM localization of RSV Gag after PI(4,5)P2 depletion 
We next wanted to determine if depletion of PI(4,5)P2 affects recruitment of RSV 
Gag to the PM.  DF1 and QT6 cells were co-transfected with DNAs expressing RSV 
Gag-GFP and myc-tagged 5ptase, or RSV Gag-GFP and a control plasmid (Fig. 2.3A).  
A second set of transfections was performed in parallel using HIV-1 Gag-GFP as a 
positive control (Fig. 2.3B).  By themselves, HIV-1 Gag-GFP and RSV Gag-GFP were 
concentrated in bright puncta at the PM, commonly interpreted to be assembling or 
budding virions, in both DF1 and QT6 cells (Fig. 2.3A and 2.3B, top panels).  Consistent  
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Fig. 2.2  Effect of 5ptase on PM localization of PH-GFP in avian cells.  DF1 (left 
panels) or QT6 (right panels) cells were co-transfected with DNAs encoding PH-GFP 
plus a control plasmid (indicated by a minus sign, top panels), or myc-tagged 5ptase 
(indicated by a plus sign, bottom panels).  Expression of 5ptase was detected by a 
monoclonal mouse anti-myc antibody (insets showing the same cells).  Images are 
single, 0.1um confocal sections through the midbody of the cell and are representative 
for each condition.  (n >30 cells). 
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Fig.	  2.3	  	  Effect	  of	  5ptase	  on	  PM	  localization	  of	  RSV	  Gag-­GFP	  and	  HIV-­1	  Gag-­
GFP.	  	  DF1	  (left	  panels)	  or	  QT6	  (right	  panels)	  cells	  were	  co-­‐transfected	  with	  DNAs	  encoding	  either	  RSV	  Gag-­‐GFP	  (A)	  or	  HIV-­‐1	  Gag-­‐GFP	  (B)	  and	  a	  control	  plasmid	  (indicated	  by	  a	  minus	  sign)	  or	  a	  plasmid	  encoding	  myc-­‐tagged	  5ptase	  (indicated	  by	  a	  plus	  sign,	  myc	  signal	  shown	  in	  insets).	  	  Images	  are	  projections	  of	  10-­‐15	  confocal	  sections	  from	  each	  cell	  compiled	  by	  average	  fluorescence	  intensity	  and	  indicate	  total	  cellular	  fluorescence.	  	  Images	  are	  representative	  for	  each	  condition	  (n	  >	  30).	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with previous reports on mammalian cells (11, 29), expression of 5ptase prevented HIV-
1 Gag-GFP from forming puncta at the PM; instead, the fluorescence signal was diffuse 
and primarily cytoplasmic (Fig. 2.3B, bottom panels).  Occasionally the HIV-1 protein 
was seen in cytoplasmic accumulations, which may correspond to intracellular vesicles 
such as late endosomes (42).  In contrast, in both types of avian cells, expression of 
5ptase had no detectable effect on the punctate fluorescence signal of RSV Gag-GFP at 
the PM (Fig. 2.3A, bottom panels).   We interpret these results to mean that, unlike HIV-
1 Gag, RSV Gag does not depend on PI(4,5)P2 for PM binding. 
To address if the RSV MBD is responsible for the lack of 5ptase effect on PM 
localization of RSV Gag, we replaced the viral MBD with the PH domain from PLC δ1, a 
cellular PI(4,5)P2-specific binding protein.  The localization of this chimeric protein was 
examined in DF1 cells and QT6 cells as described above.  In both cell types, in the 
absence of 5ptase, PHGag-GFP was observed primarily at the cell surface and in small 
vesicular structures near the cell periphery (Fig. 2.4A).  Cellular and heterologous MBDs 
have been shown previously to support budding in the HIV-1 system (30, 56).  In DF1 
cells upon co-expression of RSV PHGag-GFP with 5ptase, the fluorescence signal at 
the PM was significantly reduced.  Instead, fluorescence accumulated in large, 
cytoplasmic compartments (Fig. 2.4B, white arrows), similar to the late endosomal 
localization of HIV-1 Gag in PI(4,5)P2-depleted cells (42).  However, in some cells a 
residual fluorescence signal could be detected at the PM (Fig. 2.4A, asterisks), 
suggesting that depletion of this lipid was not uniform across the cell population.   
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Fig 2.4  Effect of PI(4,5)P2 depletion on RSV PHGag-GFP localization and 
VLP release.   DF1 or QT6 cells were co-transfected with PHGag-GFP DNA 
and control plasmid (top panels), or PHGag-GFP DNA and 5ptase DNA 
(bottom panels). The cells were processed for imaging as described for Fig. 3, 
and for VLP release as described for Fig. 4.  The 5ptase protein was detected 
by monoclonal mouse anti-myc Abs (insets).  (A) Fuorescence imaging.  In 
DF1 cells (left panels) expressing PHGag-GFP alone, the Gag chimera 
displays a strong PM localization (white arrow heads).  In cells over-
expressing 5ptase, PHGag-GFP is found predominantly at intracellular 
compartments (white arrows), although some cells display a low fluorescence 
signal at the PM (asterisks). In QT6 cells (right panels), PHGag-GFP appears 
to be unaffected by 5ptase expression.   (B) VLP release from QT6 cells.  
These cells show little or no reduction in VLP budding.  	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Unexpectedly, in QT6 cells, 5ptase caused little loss of PM fluorescence when co-
expressed with RSV PHGag-GFP (Fig. 2.4A).   
Why might phosphatase expression lead to nearly complete removal of PH-GFP 
and HIV-1 Gag-GFP from the PM but only modestly affect RSV PHGag-GFP at the PM? 
The difference between PH-GFP and PHGag-GFP might be accounted for by Gag 
multimerization in the latter, which would increase membrane affinity.  And the 
difference between RSV PHGag-GFP and HIV-1 Gag-GFP might be accounted for by 
the higher affinity of this PH domain for PI(4,5)P2  [Kd ~ 1.7μM; (34, 62)] than the affinity 
of the HIV-1 MA domain for this phosphoinositide [Kd ~ 150μM, (54)], although direct 
comparison of these values is not possible because of the different assays used and 
different fatty acid lengths of the lipid molecules.  According to this model, after 5ptase 
expression, the residual low PI(4,5)P2 levels at the PM would be sufficient to bind the 
PH domain in PHGag, given the avidity effects due to multimerization, but not sufficient 
to bind the PH domains of PH-GFP, which does not multimerize, or the MA domain of 
HIV-1 Gag, which has a lower affinity for PI(4,5)P2.  Given the differences observed in 
the two cell types, it is likely that increasing the ratio of 5ptase to Gag in transfections or 
specifically targeting 5ptase to the PM would be sufficient to prevent PHGag-GFP from 
binding the PM in QT6 cells.    
 Effect of PI(4,5)P2 depletion on virus release 
As a second approach to address the role of PI(4,5)P2 in RSV Gag PM binding, 
we measured the effect of 5ptase expression on the production of Gag-GFP VLPs.  
HIV-1 budding was previously shown to decrease by three- to five-fold upon PI(4,5)P2 
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depletion in mammalian cells (20, 42).  QT6 cells were used for these experiments 
because DF1 cells did not tolerate the toxic effects of 5ptase long enough for 
interpretable data to be obtained.  VLPs were collected by centrifugation of the medium 
24h post-transfection and quantified by western blotting.  While HIV-1 VLP release was 
decreased approximately three-fold as a result of 5ptase expression, production of RSV 
VLPs was not affected (Fig. 2.5), which is consistent with the fluorescence imaging 
results.  We also measured VLP release for the chimeric RSV PHGag-GFP protein in 
QT6 cells.  Phosphatase expression had no effect (Fig. 2.4B), consistent with the 
imaging results for this cell type.   Overall, we interpret the RSV VLP release data to 
support the observations from fluorescence imaging and conclude that PI(4,5)P2 is not 
essential for PM targeting of RSV Gag.   
Role of PIPs in binding of RSV Gag to liposomes 
In our previously published protein flotation studies, we found that recombinant, 
purified RSV MA and myristoylated HIV-1 MA bound to liposomes containing 
physiologically relevant levels of the acidic lipid PS (13, 14).  In preliminary experiments, 
addition of 1% PI(4,5)P2 to standard PC/PS (2:1) liposomes did not lead to a significant 
increase in the amount of purified protein that floated.  Based on these results and on 
computational modeling, we concluded that electrostatic interactions are the major 
factor in the binding of RSV and HIV-1 MA to membranes, rather than specific binding to 
PI(4,5)P2.  More recent work from other laboratories has focused on liposome 
interaction of the whole HIV-1 Gag protein, synthesized in vitro in a reticulocyte system 
(11, 12, 29).  These studies showed that high levels (>5%) of PIPs, including but not  
	   	   84	  
	  
	  
	  
	  
Fig. 2.5  Effect of 5ptase on virus release from QT6 cells.  QT6 cells were co-
transfected with DNAs encoding either HIV-1 Gag-GFP or RSV Gag-GFP, plus a control 
plasmid (indicated by a minus sign) or a plasmid encoding myc-tagged 5ptase 
(indicated by a plus sign).  Twenty-four hours post transfection virus-like particles 
(VLPs) were collected by centrifugation from the medium and the cells were lysed. The 
amounts of Gag-GFP in the lysate and in the VLP fractions were measured by western 
blot analysis. Virus release was calculated as the amount of extracellular Gag as a 
fraction of total Gag. Error bars represent standard deviations from the mean from three 
independent experiments.  
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limited to PI(4,5)P2 and PI(3,4,5)P3, strongly augment the interaction of HIV-1 Gag with 
PC/PS (2:1)  liposomes.    
To further investigate how PIPs influence RSV Gag interaction with membranes, 
we performed liposome flotation reactions using a truncated version of RSV Gag that is 
missing the C-terminal protease domain (GagΔPR, hereafter referred to as RSV Gag).   
This 35S-labeled protein was synthesized using a commercial reticulocyte lysate, and 
the crude mixture was incubated with extruded, 100 nm PC/PS (2:1) liposomes with or 
without added PIPs.  After centrifugation in a sucrose step gradient, the percent of 
liposome-associated protein was quantified by SDS PAGE and fluorography.  As a 
control, flotation reactions were carried out in parallel with HIV-1 Gag (11, 12, 29).   
The presence of a high molecular weight band in the membrane fraction of RSV 
Gag was observed when the proteins were resolved by SDS-PAGE, which complicated 
the analysis of the flotation data.  This band, at an apparent molecular weight greater 
than 250 kDa, was observed predominantly in the presence of PIPs.  We infer that it 
corresponds to an aggregate or an assembled oligomer of RSV Gag, since the majority 
of total protein-associated radioactivity was in Gag, as evident when the reticulocyte 
reaction was analyzed in the absence of added liposomes (data not shown).   All 
attempts to break apart this aggregate failed (see Materials and Methods).  Therefore, 
we included the high molecular species in the quantification (Fig. 2.6B, black bars). 
Compared with previous studies using purified RSV MA, RSV Gag synthesized in 
the reticulocyte lysate interacted weakly with PC/PS (2:1) liposomes, being barely 
detectable in the floated fraction (Fig. 2.6A and 2.6B).   At a concentration of 7.25% of  
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Fig. 2.6  Flotation analysis of RSV Gag and HIV-1 Gag binding to PC/PS 
and PC/PS/PIP liposomes. All liposomes were PC/PS (2:1) without or with 
(+) the addition of 7.25% PIPs.  (A, C) Representative flotation results for RSV 
Gag and HIV-1 Gag, respectively.  MB, membrane bound (floated liposomes); 
NMB, not membrane bound.  The RSV autoradiograms show the Gag band 
(white triangle) and a higher molecular weight band (black triangle) that was 
consistently observed in the presence of liposomes containing PIPs. In C the 
(*) indicates that ¼ of the total was used for the NMB samples.  (B, D) 
Quantification of three or more flotation reactions for each liposome 
composition.  The RSV quantification includes values for the Gag band only 
(white bars) or the Gag band plus higher molecular bands (black bars). (E) 
Quantification of RSV PHGag and RSV Gag (data taken from Fig. 5D).  Error 
bars represent standard deviations from the mean. 	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total lipids, diverse PIPs increased the fraction of protein that floated but with little 
evidence of specificity; mono-, di-, and tri-phosphorylated PIPs all augmented 
membrane binding (Fig. 2.6A and 2.6B).  Although PI(4,5)P2 appeared most effective, 
PI(3)P, PI(4)P, and PI(3,4,5)P3 also increased the amount of Gag protein in the 
membrane fraction by at least three-fold.  From these results, we conclude that the 
enhanced liposome interaction promoted by high concentrations of PIPs is due to 
electrostatics, not to specific recognition of the inositol head group by the RSV Gag 
protein. 
To address if RSV Gag could be converted into a specific PI(4,5)P2 binding 
protein, we created the chimeric protein described above, in which the MA domain is 
replaced by a PH domain.  RSV PHGag was found to associate with PI(4,5)P2-
containing liposomes much more strongly than RSV Gag itself, while binding to PC/PS 
liposomes was unchanged (Fig. 2.6E).  This result suggests that protein folding or other 
features of RSV Gag do not mask potential PIP interaction sites. 
Several flotation studies reported that while HIV-1 Gag binds very poorly to 
PC/PS (2:1) liposomes, this interaction is strongly enhanced by inclusion of at least 5% 
PIPs in the artificial membranes (11, 12, 54).  While PI(4,5)P2 and PI(3,4,5)P3 were 
most effective, other PIP species also augmented binding (11).  We tested the ability of 
a collection of PIPs, all at 7.25% of total lipids in PC/PS (2:1) liposomes, to promote 
HIV-1 Gag flotation (Ficure 2.6C and D).  The results confirm the weak interaction of 
Gag with PC/PS (2:1) and the strong enhancing effect of relatively high concentrations 
of PI(4,5)P2 and PI(3,4.5)P3.  However, the monophosphorylated species PI(3)P and 
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PI(4)P, which have not been tested previously, were as potent in enhancing membrane 
binding as PI(4,5)P2.   Thus our flotation data for HIV-1 do not support the prevailing 
model that HIV-1 Gag-membrane interaction has a specific requirement for PI(4,5)P2, as 
has been inferred from the properties of the phosphoinositide binding pocket in the MA 
domain reported in NMR studies of MA with short chain PIPs (54).  Rather, the data are 
more consistent with a model in which the high negative charge of the PIP head group 
acts electrostatically to attract Gag to the PM or acts directly or indirectly to induce 
myristate exposure, which then enhances membrane binding through hydrophobic 
interactions. 
In our hands, the fraction of HIV-1 Gag associated with PIP-containing liposomes 
was always at least two-fold greater than for RSV Gag.  Previously, we reported that 
RSV MA and myristoylated HIV-1 MA have similar dissociation constants governing the 
binding to PC/PS (2:1) liposomes, and that forced dimerization of these MA proteins 
strengthens liposome association (13, 14), as expected on theoretical grounds.  HIV-1 
CA and Gag dimerize with a Kd of about 10-5 M (15, 24, 31, 50), an interaction that is 
mediated by the C-terminal domain of CA.  Under similar conditions, purified RSV CA 
does not dimerize (31).  We speculate that the stronger liposome interaction of HIV-1 
Gag compared with RSV Gag is due at least in part to dimerization of the former.    
Electrostatic nature of RSV Gag binding to liposomes 
Purified RSV MA and HIV-1 MA interact more strongly with liposomes as the 
mole fraction of PS is increased (13, 14).  To examine if the corresponding Gag proteins 
in reticulocyte lysates respond in a similar manner, we performed flotation reactions at 
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different PS concentrations.  As the fraction of PS increased from 33% to 67%, the 
amount of RSV Gag that floated increased by three-fold (Fig. 2.7A, black bars).   We 
also examined a mutant RSV Gag protein called SuperM (SMGag) (6).  In this mutant, 
two acidic residues in the RSV MBD are replaced by two basic residues, leading to a 
net increase of +4 in the overall charge of the MBD.  In vivo, SMGag buds more rapidly 
than wild type Gag, and unlike wild type Gag, does not traffic through the nucleus before 
localizing to the PM (5).  These early in vivo studies led to the initial conclusion that RSV 
Gag-membrane interaction is primarily electrostatic in nature.  In the present flotation 
experiments, SMGag and wild type Gag bound PC/PS (2:1) liposomes similarly.  
However, the mutant protein responded even more strongly to increased PS 
concentrations than the wild type protein, with more than a six-fold increase (Fig. 2.7A, 
open bars).  SMGag also responded more strongly to the presence of PI(4,5)P2 than did 
wild type Gag. 
HIV-1 Gag liposome binding also rose dramatically at higher PS concentrations, 
with more than a twenty-fold increase from 33% to 67% PS (Fig. 2.7B).  These very high 
PS concentrations promoted even stronger HIV-1 Gag-liposome interaction than 7.25% 
PI(4,5)P2.  We initially considered this result to be surprising, but it was invariably 
observed with different liposome batches and translation reactions.  These results stand 
in contrast to results of previously reported experiments from the Ono laboratory, in 
which high PS concentrations could not supplant PI(4,5)P2 (11, 29).  
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Fig. 2.7  Effect of PS concentration on binding of RSV and HIV Gag to PC/PS 
liposomes.  The left-most bar or bars show liposome association in the presence of 
PI(4,5)P2 as a reference point, with the data taken from Fig. 5.  The other bars show 
liposome association at different PC:PS ratios without added PIPs.  (A) RSV Gag (black 
bars) and RSV SMGag (white bars); (B) HIV-1 Gag. 
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Taken altogether, we interpret the data from the liposome flotation assays to 
support the model that for RSV Gag and HIV-1 Gag, membrane binding in vitro is driven 
primarily by charge interactions rather than by recognition of a specific phospholipid. 
 
DISCUSSION   
We have used in vivo and biochemical assays to show that RSV Gag does not 
have a specific requirement for PI(4,5)P2 in order to associate with membranes.  
Cellular depletion of PI(4,5)P2 by over-expression of a 5-phosphatase did not reduce 
RSV Gag-GFP localization to the PM nor did it compromise release of VLPs.   In 
contrast, in parallel experiments, HIV-1 Gag-GFP localization to the PM was nearly 
ablated and VLP production was inhibited by PI(4,5)P2 depletion, as reported previously 
by others (42).  After synthesis in a reticulocyte lysate, RSV Gag protein bound weakly 
to standard PC/PS (2:1) liposomes.  While this binding was augmented by inclusion of 
7.25% PI(4,5)P2, other PIP species were equally effective in promoting binding.  High 
levels of PS, in the absence of added PIPs, enhanced binding similarly.  All of these 
results are consistent with our liposome flotation analysis of the purified RSV MA 
domain and confirm our conclusion that Gag-membrane binding is driven primarily by 
electrostatic interactions in RSV.  Therefore, we infer that even after in vivo depletion of 
PI(4,5)P2 by 5ptase, the PM apparently retains enough negatively charged lipids to 
allow RSV Gag-PM targeting and binding.  
While HIV-1 was intended primarily as a positive control, our results differ in 
some respects from those published previously.  On the one hand, PI(4,5)P2 depletion 
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abrogated HIV-1 Gag-GFP PM localization, as first found in the pioneering study by Ono 
et al (42) and later confirmed when HIV-1 was used as a control for studies on EIAV 
(20), MPMV (60), and HTLV (29), as well as in our own in vivo experiments.  On the 
other hand, our biochemical results from liposome flotation assays diverged from those 
reported earlier (11, 29).  We found no evidence of significant specificity of HIV-1 Gag 
for PI(4,5)P2.  Other PIP species as well as high levels of PS promoted similar binding 
to liposomes.  It is important to note that lack of PIP specificity in vitro does not 
necessarily contradict the observation that phosphatase-mediated depletion of PI(4,5)P2 
leads to loss of Gag-GFP at the PM.  Without a detailed understanding of the long-term 
effects of 5ptase on the pools of each phosphoinositide in different membrane 
compartments, it is not possible to directly connect biochemical data on flotation with 
fluorescence imaging of Gag-GFP in cells.  In addition, other factors may functionally 
distinguish liposome binding of reticulocyte-translated proteins in vitro from PM binding 
in vivo, for example membrane curvature, presence of other phospholipids and 
cholesterol, or presence of rabbit reticulocyte proteins capable of binding to negatively 
charged lipids or to Gag. 
What is the origin of the discrepancies between the flotation results for HIV-1 
Gag reported here and the results published previously from the Ono lab (11, 29)?  Our 
observation that PIP species other than PI(4,5)P2 also strongly promote liposome 
binding is perhaps less significant, since for those PIP species tested by both labs 
[PI(4,5)P2, PI(3,5)P2, and PI(3,4,5)P3], the raw data are not very different (11). However, 
our finding that high PS promotes HIV-1 Gag binding at least as strongly as 7% 
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PI(4,5)P2 is in strikingly contrast to published results, which showed only marginal Gag 
binding to liposomes with 60% PS (11, 12, 29).  We tested and eliminated several 
possible explanations for this discrepancy, including different HIV-1 strain background 
(BH10 versus NL4-3), different origins of lipids (brain-derived versus synthetic), and 
different Gag structures (lacking or including the p6 domain).  Instead, the explanation 
appears to lie in the methods of liposome preparation and possibly the method of 
flotation. The previously reported experiments were carried out with liposomes that had 
been made by sonication in plastic tubes emersed in a water bath, conditions that are 
unlikely to effectively break up large multilamellar vesicles (G. Feigenson, personal 
communication). Our liposomes were made by repeated extrusion through a 100nm 
filter, which is expected to produce small unilamellar vesicles and consequently a much 
larger available surface area.  We traded liposome preparations with the Ono lab, and in 
preliminary experiments confirmed the published results that for these sonicated 
liposomes, HIV-1 Gag floated much more extensively at 2:1 PC:PS + 7% PI(4,5)P2 than 
at 1:1 PC: PS.  In parallel, for our extruded liposomes, HIV-1 Gag bound more 
extensively at 1:1 PC:PS than at 2:1 PC:PS + 7% PI(4,5)P2. The Ono lab observed a 
similar trend, although with quantitatively less flotation for the extruded than for the 
sonicated liposomes.  We speculate that the differences in accessible membrane 
surface area, and perhaps also differences in liposome size and buoyant density, as 
well as differences in centrifugation conditions, lead to the very different measurements 
of ability of HIV-1 Gag in the crude reticulocyte lysate to attach to artificial membranes.  
For example, basic reticulocyte proteins, which might be in vast excess over the 
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translated radioactive HIV-1 Gag, might cover the smaller membrane surface of 
multilamellar liposomes and thereby prevent the weak binding of Gag to PS.    
The role of PI(4,5)P2 in retroviral Gag-membrane interaction has been addressed 
for several retroviruses but with divergent results for different experimental settings and 
different viruses.  In HIV-1, early work on in vitro assembly of purified Gag protein, in the 
absence of membranes, first suggested the importance of phosphoinositides.  Assembly 
of properly sized VLPs required inositol hexakisphosphate or pentakisphosphate (7), 
which were interpreted to mimic a phosphoinositide in cells, possibly PI(3,4,5)P3.  Some 
of the side chains interacting with these highly charged molecules have been mapped 
(57).  In the original study by Ono et al (42), phosphatase-mediated depletion of 
PI(4,5)P2 was found to redirect Gag-GFP away from the PM.  A binding pocket for short 
chain PI(4,5)P2 (54), which was later also identified for HIV-2 (51), suggested that this 
lipid species is responsible for HIV-1 Gag PM localization.  More recently, PI(4,5)P2 was 
found to be significantly enriched in HIV-1 virions (9). 
As measured by NMR, EIAV MA also was found to bind short chain PIPs, but in 
this case several PIP species had higher affinities than PI(4,5)P2 (20). Early 
experiments were interpreted to mean that EIAV MA can bind to neutral liposomes but 
that membrane association is strongly enhanced by acidic lipids (48).  However, in a 
more recent report, PM fluorescence of EIAV Gag-GFP was not affected by expression 
of 5ptase, although a possibly more potent PIP phosphatase induced major changes in 
subcellular localization (20).   
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In the MLV system, expression of 5ptase reduced MLV VLP release (25), as in 
the case of HIV-1.  Also, PI(4,5)P2 was found to be enriched in virions (9).   In vitro, 
PIPs in PC liposomes were found to be required for binding of MA (25), but the MA was 
unmyristoylated and thus the biological significance is uncertain.  This stimulatory effect 
was quantitatively similar for diverse PIPs, and little or no binding was observed to 
liposomes containing only PS.  However, in the presence of 20% PS, PI(4,5)P2 
specifically stimulated MA binding with a four-fold lower apparent Kd than other PIPs, 
suggesting a synergism between these two negatively charged lipids.  
Finally, HTLV-1 Gag and chimeric Gag proteins bearing the HTLV-1 MA domain 
did not show a specific requirement for PI(4,5)P2 , either for PM localization in cells or 
for liposome binding from reticulocyte lysates.  However, acidic phospholipids, including 
PIPs, stimulated liposome binding, similar to what we have observed for RSV Gag.  
Altogether, these diverse results for different retrovirus Gag proteins suggest that if a 
head group-specific PI(4,5)P2 interaction is biologically important, it  may be limited to 
HIV-1 Gag and its close relatives.   
In overview, at least five principles underlie PM targeting of retroviral Gag 
proteins.  First, vesicular trafficking appears to play a central role, as demonstrated by 
the interaction of the HIV-1 MA domain with clathrin adapter protein AP3 and the effects 
of knocking out this binding (17).  But understanding of the trafficking pathway by which 
any Gag protein reaches the PM remains rudimentary and controversial, despite 
attempts to follow this kinetically (46).   
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Second, as described above, a PI(4,5)P2 head group–specific binding pocket has 
been identified at the atomic level by NMR for HIV-1 and HIV-2 (51, 54).  According to 
the myristoyl switch model proposed by these studies (23, 52-54), one of the fatty acid 
chains of PI(4,5)P2 is extracted from the lipid bilayer and is bound to a hydrophobic 
groove in MA, just as the N-terminal myristate is extracted from its pocket in MA and 
becomes inserted into the membrane.   In this model, it remains uncertain how the 
formidable energy barrier would be overcome to promote the movement of a fatty acid 
chain from the lipid bilayer into a hydrophobic groove in a protein.  The biochemical 
experiments on which the model is based, as well as the NMR experiments measuring 
the affinities of EIAV MA protein for purified phosphoinositides (20), were necessarily 
carried out with short chain PIPs to maintain their solubility.  A recent study using 
surface plasmon resonance to measure PIP binding to HIV-1 Gag concluded that the 
lengths of the PIP acyl chains are the major contributing factor in determining the PIP 
binding affinity of HIV-1 Gag, not the phosphorylation state of the inositol head group 
(3).  Thus, the biological relevance of studies with short chain PIPs remains to be 
established.  Finally, interpreting the effects of 5ptase-mediated depletion of PI(4,5)P2 
on Gag PM localization may be more difficult than commonly assumed.  To date, all 
retrovirus studies on 5ptase-depletion, including ours, have been long-term, with the 
endpoints representing a cumulative effect of the phosphatase over many hours.  
Secondary effects of perturbing PIP pools are almost certain to occur and thus limit the 
interpretations of fluorescence imaging.  All eukaryotic cells maintain tight control of the 
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concentrations and localization of PIPs, which probably explains why over-expression of 
5ptase can trigger apoptosis in some cell types at least in some cell types. 
Third, hydrophobic interactions are critical in mediating membrane interactions 
for those Gag proteins modified by an N-terminal myristate, like HIV-1 Gag and MLV 
Gag.  It is widely accepted that insertion of a single fatty acid into a lipid bilayer is 
insufficient to lock a protein into the membrane.  In the absence of other membrane 
binding features, a subpopulation of proteins will be cytosolic as the fatty acid moiety 
samples the aqueous space.  In the case of retroviral Gag proteins, several factors, 
including multimerization of Gag (61), binding of the MA domain to PIPs (1, 51, 54), or 
membrane proximity, can tip this balance toward membrane attachment.   By bringing 
the myristate into close proximity to the PM, electrostatic interactions between the MBD 
and acidic phospholipids favor insertion of the myristate into the lipid bilayer where it is 
more stable.  The quantitative contributions of these factors in promoting myristate 
insertion are unknown. Because of the complexity in understanding the behavior of 
myristate and protein binding grooves for it, the nature of retroviral Gag-membrane 
interaction may be easiest to work out for viruses like RSV, which rely primarily on 
electrostatic interactions with membranes. 
Fourth, multimerization of any membrane-binding protein increases its avidity for 
the membrane, and this property is intrinsic to Gag.  Multimerization is expected to be 
concentration-dependent, and hence expression levels also should affect membrane 
binding, as found experimentally for HIV-1 MA (45).  To date, the effects of 
multimerization on membrane binding have been modeled experimentally and 
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computationally only by dimerization, using RSV MA and HIV MA proteins that were 
induced to dimerize artificially.  The behavior of higher order multimers, which might be 
formed in the cytoplasm or assembled on the membrane, has not been studied.  Once a 
Gag lattice has grown beyond a minimal size, the lattice probably would remain firmly 
attached to the PM even after depletion of PI(4,5)P2.  The role of kinetics in PM binding, 
which is likely to be critical, has not been addressed in any study.  Future work on the 
effects of multimerization and of PI(4,5)P2 depletion in Gag PM binding may require 
truncated or mutated Gag proteins that do not multimerize (18). 
Fifth, electrostatic interactions appear to be universal in Gag membrane 
targeting, perhaps providing the major force directing Gag to the PM.  All MA proteins 
have basic patches on the membrane-proximal surface (40), and the inner leaflet of the 
PM is unique in its high concentration of acidic lipids.  This negative charge results 
mainly from PS and PI(4,5)P2, but the relative contributions of each of these lipids are 
not well understood and may depend on cell type (27, 67).  In addition, clustering of 
lipids in membranes may result in formation of microdomains with different charges.  
Fluorescent protein sensors have been developed to probe for the overall negative 
potential of the inner leaflet. These probes are based on a positively charged segment 
of polypeptide plus a lipid anchor that by itself is insufficient for steady state PM 
localization (67).  Such probes, together with PH-GFP and fluorescently marked Gag 
proteins, could help elucidate if the electrostatic interactions between MA domains and 
the PM are powered primarily by PI(4,5)P2, by PS, or by a combination of the two.  
Different retroviruses probably lie on a gamut, with some relying more on PI(4,5)P2 and 
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others relying more on PS.  Gag proteins that rely more on PI(4,5)P2 may do so in part 
because of a specific binding pocket for the head group or because of a local clustering 
of basic residues that is preferentially attracted to the multiple negative charges of this 
lipid.  The latter effect could explain the frequently reported strong effects of PIPs in 
flotation analyses but without specificity for PI(4,5)P2.  In summary, we propose as a 
unified, working model that not only RSV Gag, but all retroviral Gag proteins rely 
primarily on electrostatic interactions to drive at least the first steps in PM binding.   
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CHAPTER 3	  
HIV-1 GAG PROTEIN CAN SENSE THE CHOLESTEROL AND ACYL 
CHAIN ENVIRONMENT IN MODEL MEMBRANES2 
 
 Membrane binding of the HIV-1 Gag structural protein, a critical step in viral 
assembly at the plasma membrane, is mediated by the myristoylated, highly basic MA 
domain, which interacts with negatively charged lipids in the inner leaflet.  According to 
a popular model, virus particles bud from membrane rafts, microdomains enriched in 
cholesterol and high-melting phospholipids with higher order than found outside of rafts.  
How Gag might recognize membrane rafts, if they exist in the inner leaflet, is unknown. 
Using a liposome flotation assay with proteins translated in vitro, we investigated if Gag 
can sense the composition of the hydrophobic part of the bilayer, by fixing lipid head 
group composition and varying hydrophobic properties.  In liposomes composed solely 
of phosphatidylserine and phosphatidylcholine, and with the same overall membrane 
negative charge, Gag strongly preferred lipids with both acyl chains unsaturated, over 
those with only one chain unsaturated.  Adding cholesterol increased Gag binding and 
led to closer p3acking of phospholipids.  However, higher membrane order, as 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 The following section is reproduced from: Dick, R. A., S. L. Goh, G. W. Feigenson, and 
V. M. Vogt. 2012. HIV-1 Gag protein can sense the cholesterol and acyl chain 
environment in model membranes. Proc Natl Acad Sci U S A 109:18761-6, with 
modifications to conform to the required format. R.A.D. performed liposome flotatation 
and protein purification. S.L.G. performed ESR measurements.	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measured by electron spin resonance, was not correlated with increased Gag binding.  
Gag proteins from two other retroviruses gave similar results.  These liposome binding 
preferences were qualitatively recapitulated by purified myristoylated HIV-1 MA.  
Phosphatidylinositol (4,5)bisphosphate and cholesterol enhanced binding in an additive 
manner.  Taken together, these results show that Gag is sensitive to both the acyl 
chains of phosphatidylserine, as well as cholesterol concentration and other details of 
the membrane environment.  These observations may help explain how retroviruses 
acquire a raft-like lipid composition. 
 
INTRODUCTION  
The retroviral structural polyprotein, Gag, drives virus assembly at the plasma 
membrane (PM).  Gag molecules bind to the PM, and then through protein-protein 
interactions form a curved lattice that bulges out and eventually leads to budding and 
release of the enveloped virus particles.  HIV-1 Gag interacts with the negatively 
charged inner leaflet of the PM primarily via its N-terminal MA domain.  Three features 
of MA underlie HIV-1 Gag membrane binding: an N-terminal myristate, a highly basic 
patch, and a pocket for the minor lipid phosphatidylinositol bisphosphate, PI(4,5)P2 (1).  
Multimerization and vesicular trafficking also play roles in membrane interaction in vivo.  
PI(4,5)P2 is important in vivo, based on the observations that its depletion by an 
overexpressed phosphatase compromises budding (2), and that it is enriched in the 
HIV-1 envelope (3). In vitro and biochemical assays qualitatively support the 
conclusions about Gag-PM interaction in vivo:  In vitro flotation assays show HIV-1 Gag 
	   	   111	  
	  
	  
	  
binding to liposomes to be dependent on negatively charged lipids, in particular 
phosphatidylserine (PS) (4), which is enriched in the inner leaflet of the PM.  Liposome 
binding is enhanced by the addition of PI(4,5)P2 (5), although without great specificity 
for this particular phosphoinositide (5, 6). 
HIV-1 is said to bud from rafts (reviewed in (7)).  Diverse strands of evidence 
support this model.  First, cellular proteins found in rafts are often associated with viral 
particles (8).  Second, the envelopes of retroviruses like HIV-1 (3, 9, 10) and Rous 
sarcoma virus (RSV) (11, 12) are enriched in sphingomyelin (SM) and cholesterol, 
compared with the PM.  Third, two retroviral proteins—Nef for HIV-1 and Glycogag for 
murine leukemia virus (MLV) —promote cholesterol incorporation into virus particles 
and raft association of Gag (13, 14).  Fourth, cholesterol depletion from cells reduces 
HIV-1 release (15).  But how virus particles acquire the observed high cholesterol 
content is unknown.  For example, Gag might prefer to bind to raft-like micro-domains, 
or the lattice of Gag molecules might induce raft formation de novo, or Gag might cause 
coalescence of pre-existing raft domains (16). Few studies have addressed such 
questions in vitro.  In chemically simple, lipid-only models of the PM outer leaflet, a large 
region of compositions is found in which two phases coexist, the liquid-disordered or Ld 
phase, and the liquid-ordered, or Lo phase.  This compositional region can be termed 
“the raft region”.  The minimal lipid requirement for Ld + Lo coexistence in a mixture is a 
high melting temperature (Tm) lipid such as SM or distearoyl phosphatidylcholine 
(DSPC), a low Tm lipid such as dioleoyl phosphatidylcholine (DOPC) or palmitoyl, oleoyl 
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phosphatidylcholine (POPC), and cholesterol.  Compared with the Ld phase, the Lo 
phase is enriched in the high Tm lipid and in cholesterol in these simple mixtures. 
 A major challenge to understanding how HIV-1 acquires a raft-like lipid 
composition is that rafts are known only for the outer leaflet of the PM, yet Gag interacts 
directly with the inner leaflet.  By composition, the inner leaflet has no high Tm lipid, has 
lower concentrations of PC, and has high concentrations of PE, PS, and cholesterol 
(17).  No Ld + Lo coexistence has been observed in bilayer models representing the 
composition of the inner leaflet (18).  
Here, we investigated how cholesterol and phospholipid acyl chain type affect 
HIV-1 Gag binding to liposomes in vitro, as measured by Gag flotation in sucrose 
gradients.  While still not a good mimic of the properties of the inner leaflet, we chose 
simplified model mixtures of PS/PC or PS/PC/cholesterol, because the phase behaviors 
of similar mixtures are relatively well understood, and accurate phase diagrams could 
be used to guide mixture choices (19).  Results show that Gag-membrane interactions 
depend on phospholipid head group type, as known previously, but notably also on 
cholesterol concentration and on acyl chain saturation. 
 
MATERIALS AND METHODS  
Plasmids, protein purification, liposome preparation, and electron spin resonance 
The plasmids encoding HIV GagΔp6 BH10 and RSV GagΔPR, and encoding 
myristoylated HIV-1 MA (myr-MA), as well as the purification procedure for myr-MA 
were previously described (4, 25) or are detailed in the Supplementary section.  
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 Liposome preparation.  Liposomes were prepared by the rapid solvent 
exchange (RSE) method (26) modified as described (27). Briefly, lipids in chloroform 
solution were dispensed into glass tubes. After the addition of buffer (20 mM HEPES, 
pH 7.0), the mixture was vortexed under vacuum for 90 s and sealed under argon gas, 
yielding 10 mg/mL hydrated liposomes. Liposome samples were stored at 4°C up to one 
week before extrusion. To prepare large unilamellar vesicles (LUVs), a mini-extruder 
block (Avanti) was heated to 45°C.  Liposomes were extruded 41 times through 100 nm 
polycarbonate filters (Avanti) and stored at 4°C. Extruded liposomes were used within 
one week. Details of the methods used to handle lipids (28) and to prepare samples for 
ESR measurements can be found in the Supplementary section. For ESR 
measurements typical instrument settings were: center field = 3320 G, sweep width = 
100 G, modulation frequency = 100 kHz, modulation amplitude = 1 G, time constant = 
conversion time = 81.92 s, resolution = 2000 points. Nine scans were averaged for each 
sample. Amax and Amin were determined directly from the spectra, and the order 
parameter of each sample was calculated according to Schorn & Marsh (29) using the 
hyperfine tensor (Axx, Ayy, Azz) = (5.9, 5.4, 32.9 G). 
Liposome binding assay 
Radioactively labeled protein was prepared by translation in the TnT coupled T7 
rabbit reticulocyte reaction (Promega) in the presence of [35S] methionine-cysteine 
(Perkin Elmer: ExPRE35S35 protein labeling mix). The liposome binding assay used for 
Fig. 3.1 and 3.2, here referred to as large format assay, was previously described (6). A 
small format liposome binding assay was used for Fig. 3.3-3.6 as previously described 
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(20) with some modification. A 5 mL fraction of a 25 mL reticulocyte transcription 
reaction was added to 15 mL binding buffer (20mM HEPES pH 7.0) followed by 50 mg 
of LUVs (to a concentration of 8.5 mg/mL). The reaction mix was incubated at 22°C for 
10min. Each binding reaction was mixed with 75 mL 67% sucrose, and 80 mL of this 
mix was placed in a TLA 100 tube followed by 120 mL 40% sucrose and 40 mL 4% 
sucrose. All sucrose was made w/w with binding buffer. Centrifugation was at 90k rpm 
in a TLA 100 rotor (Beckman) for 1 hr. Purified myr-MA flotations were performed with 
15 mg of protein in place of the reticulocyte reaction, and the binding buffer and sucrose 
was supplemented with with NaCl so that all solutions were at a final concentration of 
150 mM NaCl. Four 60 ml fractions were collected from each flotation and 40 ml of each 
fraction was analyzed by SDS-PAGE. 
 
RESULTS AND DISCUSSION 
 We examined how membrane negative charge, cholesterol concentration, and 
phospholipid acyl chain properties affect HIV-1 Gag membrane binding.  Radiolabeled 
Gag was synthesized in vitro in a reticulocyte translation system.  Binding to 100 nm 
large unilamellar vesicles (LUVs) was measured by flotation in a sucrose gradient (5, 6, 
20, 21).   
Effects of acyl chain saturation on HIV-1 Gag binding 
Increasing the ratio of PS to PC is known to increase the binding of Gag to LUVs 
(4-6, 20). To test if Gag is sensitive to acyl chain length and saturation, PC- and PS-
containing LUVs were prepared with three acyl chain types: DOPC/DOPS, where both 
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lipids have two 18:1 (oleoyl) chains; POPC/POPS where one fatty acid is 16:0, the other 
18:1 (palmitoyl, oleoyl); and egg PC/brain PS, a natural mixture, with the PC being 32% 
16:0, 32% 18:1, 12% 18:0, and 17% 18:2, and the PS being dominated by 18:0, 18:1 
chains.  By keeping the PS and PC chains identical or nearly so, comparisons of each 
mixture focus on the behavior of the particular PS chains, rather than on the way 
disparate PS and PC chains might mix. 
As PS concentration increased from 20% to 90%, binding of HIV-1 Gag to LUVs 
with mixtures of the three acyl chain types differed (Fig. 3.1).  Gag binding to 
DOPC/DOPS increased steeply at ~30% PS, reaching a maximum at ~ 50% PS.  Gag 
binding to POPC/POPS only gradually increased starting at ~30% PS, reaching a 
somewhat lower maximum.  Finally, Gag binding to natural PC/PS again increased 
gradually starting at ~30% PS, reached a maximum at ~ 65% PS, and then gradually 
decreased at higher PS concentrations.  The membrane charge seen by Gag is not 
different among these mixtures at any given PS concentration (22).  Yet surprisingly, 
Gag behaves as if it experiences a greater effective PS concentration in the 
DOPC/DOPC mixtures. 
Cholesterol-enhanced binding of Gag 
The effect of cholesterol on membrane binding of retroviral Gag proteins in vitro 
has not been investigated systematically.  We measured Gag binding to LUVs with 
increasing cholesterol content in four different phospholipid environments, including one 
that mimics Lo and Ld compositions: DSPC/DOPC/DOPS, DOPC/DOPS, POPC/POPS, 
and egg PC/brain PS (DSPC is distearoyl phosphatidylcholine, 18:0, 18:0-PC).  In each  
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Fig. 3.1  Acyl chain saturation influences phosphatidylserine-driven HIV-1 Gag 
liposome binding.  35S-methionine-labeled HIV-1 Gag synthesized in a reticulocyte 
extract was incubated with liposomes composed of one of the following three mixtures 
of two phospholipids:  dioleoyl-PC (DOPC) and dioleoyl-PS (DOPS); palmitoyl, oleoyl-
PC (POPC) and palmitoyl, oleoyl-PS (POPS); or egg PC and brain PS. [The oleoyl acyl 
chain has one double bond (18:1), while the palmitoyl acyl chain has no double bonds 
(16:0)].  The percentage of Gag that floated with the liposomes in a sucrose gradient, as 
determined by SDS-PAGE and fluorography, was plotted as a function of increasing 
concentration of the negatively charged lipid PS.  Error bars indicate standard deviation 
for replicas done at 40% and 80% PS for all three lipid compositions and at 60% and 
70% PS for the natural phospholipids 
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different lipid mixture, the percentage of cholesterol was increased while the percentage 
of PC was decreased, keeping PS unchanged at 30%.  The maximum cholesterol 
content, 63%, is near its solubility limit in PC mixtures (23).  The resulting cholesterol 
concentrations cover the cholesterol concentration of plasma membranes, which can be 
as high as 50% (17). For all four mixtures tested, increased cholesterol concentration 
resulted in increased binding of Gag, as shown by the fluorograms (Fig. 3.2A) and in 
more detail in Fig. 3.2B.   Two distinct behaviors are observed, characterized by 
different shapes of the binding curves: (i) In the two DOPC-containing mixtures, Gag 
binding increased strongly starting at the lowest cholesterol concentrations, rising to 
nearly maximal binding at ~36% cholesterol.  This behavior occurred whether or not the 
mixtures contained 5% of the saturated acyl chain lipid DSPC; (ii) In egg PC/brain PS 
mixtures, Gag binding started to increase only at ~18% cholesterol, then rose gradually 
toward the same maximum found with the DOPC-containing mixtures.  In POPC-
containing mixtures the curve shape was similar, but with binding first detected at ~36% 
cholesterol, and gradually increasing to a slightly lower maximum.  This cholesterol-
mediated enhancement of HIV-1 Gag binding in these simple model liposomes might 
mimic the association of HIV-1 Gag with cholesterol-containing plasma membranes, and 
in particular with lipid raft microdomains in the membrane. 
Adding cholesterol to phospholipid bilayers increases the packing density of 
phospholipid acyl chains and headgroups, the well-known “cholesterol condensing 
effect” (24). Closer lipid packing means increased acyl chain order, a parameter that 
can be measured by electron spin resonance (ESR) with spin-labeled lipid probes.  We  
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Fig. 3.2  Cholesterol concentration influences HIV-1 Gag binding to 
liposomes.  Liposomes were made with a fixed 30% PS and varying ratios of 
cholesterol and DOPC or POPC (and in one case also containing 5% 
distearoyl PC (DSPC), 18:0, 18:0).  HIV-1 Gag synthesis and flotation 
analyses were as described in Fig. 1.  A, Examples of lipid ratios for each of 
the four lipid compositions used and the corresponding fluorograms. MB, 
membrane bound (floated liposomes); NMB, non-membrane bound (1/4 of the 
sample loaded compared with MB).  B, Quantification of flotation reactions. 
The symbols are the same as in A.  Error bars represent standard deviation 
for the three, three-component mixtures repeated in triplicate at 9% and 36% 
cholesterol, for DOPC/DOPS/0% cholesterol, and for eggPC/brainPS/45% 
cholesterol.  C, Electron spin resonance (ESR) measurements for each of the 
four liposome compositions from 0% to 63% cholesterol. S, order parameter.  	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carried out ESR measurements on all four mixtures with 16-DOXYL-stearic acid (16-
DSA).  Increased cholesterol concentration clearly increased lipid order (Fig. 3.2C), yet 
the order was not correlated with the Gag binding differences seen in Fig. 3.2B.  In 
particular, at every cholesterol concentration, Gag behaved as if it detected a higher PS 
concentration in DOPS-containing mixtures than in POPS or brain-PS mixtures. 
Effects of lipid order on Gag membrane interaction 
In order to explore more systematically the model that "viruses bud from rafts", 
we selected lipid mixtures that are closer in composition to actual Ld and Lo phases, 
based on published phase diagrams (19).  We avoided phase coexistence regions by 
choosing cholesterol concentration just higher than the Ld + Lo coexistence region. Two 
kinds of mixtures were examined, one containing DOPC, the other POPC.  We prepared 
four series of LUVs, two with constant cholesterol = 40% and PS = 20%, and two with 
constant cholesterol = 32% and PS = 30%.  In all four mixtures, membrane order was 
systematically varied by changing the ratio of high-melting, saturated DSPC to low-
melting, unsaturated lipids. Thereby, the LUV compositions ranged from liquid-
disordered to liquid-ordered (Fig. 3.3A, 3.3B; see Table 3.1 for all lipid compositions). 
Two sets of eight compositions were prepared for the DOPC and two for the POPC 
mixtures, each lying on a line of constant cholesterol concentration and extending from 
all low-Tm (Ld) lipid on the left to all high-Tm (Lo) lipid on the right.  Because Gag 
binding to DOPC/DOPS/cholesterol at 40% cholesterol was nearly maximal at 30% PS 
(Fig. 3.2B), the PS in the DOPC-containing mixture was reduced to a fixed 20% in order 
to increase the dynamic range for observing Gag binding in these mixtures.   
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Fig. 3.3  Membrane order has complex influence on HIV-1 Gag-liposome 
binding at fixed PS and cholesterol concentrations. HIV-1 Gag and 
flotation analyses were as described in Fig. 1.  A and B, phase diagrams 
situate the DOPC and POPC mixtures tested relative to the Ld + Lo phase 
coexistence region.   A.  The left-most triangle symbol crossing the Low Tm 
Lipid axis represents a composition of low Tm lipids DOPC/DOPS/cholesterol 
(40%/20%/40%).  Each triangle moving sequentially to the right has an 
additional 5.7% DOPC replaced with 5.7% of the high Tm lipid DSPC. The 
right-most X symbol represents a composition of high Tm lipids 
DSPC/DPPS/cholesterol (40%/20%/40%). Each X moving sequentially to the 
left has 5.7% DSPC replaced by 5.7% of the low Tm DOPC.  Note that the 
boundaries of the four-component phase diagrams containing PS have not 
been determined, but are shown here based on the published three-
component phase diagrams (19), in order to provide a guide to the expected 
phase behavior of the four-component PS-containing mixtures.  B. As in A, 
except with POPC lipids instead of DOPC lipids.  The left starting point for the 
low Tm lipids POPC/POPS/cholesterol (38%/30%/32%) is marked by a circle, 
with each sequential point having 5.4% POPC replaced by 5.4% of the high 
Tm lipid DSPC. The right starting point for the high Tm lipids 
DSPC/DPPS/cholesterol (38%/30%/32%) is marked by a dash, with each 
sequential point having 5.4% DSPC replaced with 5.4% of the low Tm lipid 
POPC.  All compositions yield a single phase (i.e. not coexistence of the two 
phases, Ld+Lo).  Lipid order increases from the left to right (Ld to Lo) as the 
percentage of high Tm lipid increases.  C and E, ESR and Gag binding 
measurements for the DOPC-containing liposomes.  D and F, ESR and Gag 
binding measurements for the POPC-containing liposomes. The symbols in C 
and D are the same as those in A and B.  Error bars represent standard 
deviation for at least three replicas for each data point.  	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DOPC-
Mixture % DSPC % DOPC % DOPS % Chol 
Ld-1 0 40 20 40 
Ld-2 5.7 34.3 20 40 
Ld-3 11.4 28.6 20 40 
Ld-4 17.1 22.9 20 40 
Ld-5 22.8 17.2 20 40 
Ld-6 28.5 11.5 20 40 
Ld-7 34.2 5.8 20 40 
Ld-8 40 0 20 40 
     
     
     
DOPC-
Mixture % DSPC % DOPC % DPPS % Chol 
Lo-1 0 40 20 40 
Lo-2 5.8 34.2 20 40 
Lo-3 11.5 28.5 20 40 
Lo-4 17.2 22.8 20 40 
Lo-5 22.9 17.1 20 40 
Lo-6 28.6 11.4 20 40 
Lo-7 34.3 5.7 20 40 
Lo-8 40 0 20 40 
     
     
     
POPC-
Mixture % DSPC % POPC % POPS % Chol 
Ld-1 0 38 30 32 
Ld-2 5.4 32.6 30 32 
Ld-3 10.8 27.2 30 32 
Ld-4 16.2 21.8 30 32 
Ld-5 21.6 16.4 30 32 
Ld-6 27 11 30 32 
Ld-7 32.4 5.6 30 32 
Ld-8 38 0 30 32 
     
     
     
POPC-
Mixture % DSPC % POPC % DPPS % Chol 
Lo-1 0 38 30 32 
Lo-2 5.6 32.4 30 32 
Lo-3 11 27 30 32 
Lo-4 16.4 21.6 30 32 
Lo-5 21.8 16.2 30 32 
Lo-6 27.2 10.8 30 32 
Lo-7 32.6 5.4 30 32 
Lo-8 38 0 30 32 
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Table 3.1  Compositions of liposomes used in Fig. 3.3. All components of 
each sample are mole % of total lipids. The DOPC-mixture liposomes, Ld-1 to 
Ld-8 and Lo-1 to Lo-8 correspond to the triangle and x symbols in Fig 3 
respectively. The POPC-mixture liposomes, Ld-1 to Ld-8 and Lo-1 to Lo-8 
correspond to the circle and dash symbols in Fig 3 respectively. 	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ESR measurements showed that increasing the percentage of high Tm lipids 
increased membrane order, regardless of whether DOPS or DPPS was in the mixtures 
(Fig. 3.3C, D).  Comparing 3.3C with 3.3D, at each high Tm lipid percentage up to 
~50%, the DOPC-containing mixture had slightly lower order than did the POPC-
containing  
mixture, indicating that the saturated acyl chain of POPC confers more order to the 
mixture despite the lower cholesterol concentration of 32% compared with 40%. 
We found that Gag binding in these mixtures was not a function of membrane 
order.  Whereas order increased gradually and monotonically as high Tm lipid 
concentration increased, Gag binding exhibited dramatic differences.  For 20% DOPS in 
the 40% cholesterol/DOPC/DSPC mixtures (triangle symbols), replacing DOPC with the 
high Tm DSPC resulted in nearly unchanged Gag binding for the eight LUV 
compositions (Fig. 3.3E).  In stark contrast, for 20% DPPS in the 40% 
cholesterol/DOPC/DSPC mixtures (x symbols), Gag binding was barely detectable for 
any replacement of DOPC by DSPC (Fig. 3.3E).  This surprising result was reproducible 
in multiple LUV preparations.  Thus, in a variety of membrane environments, including 
some that are very similar to those resulting in strong Gag binding to DOPS, Gag 
behaves as if it hardly detects the 20% DPPS at all. 
Quite different Gag binding occurred with only subtle changes in lipid composition 
in the POPC-containing mixtures (Fig. 3.3F): For 30% POPS in 32% 
cholesterol/POPC/DSPC mixtures (open circle symbols), replacing POPC with DSPC 
hardly changed Gag binding, which decreased only slightly when DSPC reached 38%.  
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In contrast, for 30% DPPS in the 32% cholesterol/POPC/DSPC mixtures, Gag binding at 
first remained high as DSPC replaced POPC, then gradually dropped toward ~0 as the 
POPC was completely replaced by DSPC (Fig. 3.3F).  In remarkable contrast to the 
behavior of DOPC-containing mixtures at 40% cholesterol where very low Gag binding 
occurred when the PS was 20% DPPS, high Gag binding was observed in mixtures 
containing 30% DPPS in POPC-containing mixtures with 32% cholesterol.  Thus, Gag 
binds well to DPPS, but only in mixtures in which the DPPS is in some sense sufficiently 
"available" to the Gag.  
These data show that cholesterol enhancement of HIV-1 Gag-liposome binding is 
not solely a consequence of a cholesterol-induced increase in membrane order.  
Instead, the data imply that Gag detects three lipid mixture features besides PS 
concentration: (i) the ensemble of all acyl chains in the membrane; (ii) the cholesterol 
concentration; and (iii) the nature of the acyl chains of the negatively charged PS with 
which Gag interacts. 
Response of other retroviral Gag proteins to cholesterol and phospholipid acyl chain 
type 
To determine if the sensing of differences in the content of cholesterol and acyl 
chains in liposomes is unique to HIV-1 Gag, we tested MLV Gag and RSV Gag proteins 
in parallel with HIV-1 Gag.  MLV Gag also is naturally myristoylated at its N-terminus, 
but RSV Gag is not lipidated in any way. In order to mimic the differences between Ld 
and Lo phases, two pairs of LUVs were prepared for each protein: (i) 30% brain PS + 
egg PC with or without 36% cholesterol; and (ii) 30% PS, but with compositions chosen 
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close to those of known Ld + Lo phase coexistence (19) and with membrane order 
characteristic of an Ld mixture or of an Lo mixture.   
HIV-1, RSV, and MLV Gag proteins all responded similarly to these LUV mimics 
of Ld and Lo phases, preferring liposomes containing high cholesterol concentration 
coupled with acyl chain saturation (Fig. 3.4).  Only in the case of the 0% and 36% 
cholesterol LUVs did RSV Gag bind without significant difference. Thus Gag sensing of 
the acyl chain composition does not require an N-terminal fatty acid chain. However, the 
preference for the Lo composition seen here does not indicate that membrane order 
alone is the explanation.   The HIV-1 Gag binding shown in Fig. 3.3E, F makes clear 
that the nature of the PS acyl chains, the cholesterol concentration, and the acyl chains 
of other lipids present all have strong influence on Gag binding. 
 An advantage of the reticulocyte extract is that it simulates a cellular 
environment, for example by the presence of RNA and proteins. A disadvantage is that 
unknown components might influence Gag binding.  Therefore, we tested the binding of 
non-radioactively labeled, myristoylated HIV-1 MA protein (myr-MA) that had been 
purified after expression in E. coli (4, 25).  Myr-MA behaved similarly to HIV-1 Gag in 
that the presence of cholesterol strongly enhanced binding to LUVs (Fig. 3.5).  And like 
Gag, purified myr-MA also preferred the LUVs with the Lo composition, corroborating 
results from the reticulocyte experiments. 
PI(4,5)P2-enhanced membrane binding in the presence of cholesterol 
Because of the established role of PI(4,5)P2 in membrane binding, we examined 
the ability of cholesterol to stimulate binding of HIV-1 Gag to LUVs containing PI(4,5)P2.   
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Fig. 3.4  Acyl chain type and presence of cholesterol influence liposome binding 
of other retroviral Gag proteins. The three Gag proteins were expressed in a 
reticulocyte lysate and analyzed by flotation as in Fig. 1.  RSV, Rous sarcoma virus 
(alpharetrovirus genus); MLV, murine leukemia virus (gamma retrovirus genus). The 
lipid compositions were as follows: 0% = 70% eggPC/30% brainPS;  36% = 34% 
eggPC/30% brainPS/36% cholesterol (white bars);  Ld =  10% DSPC/30% POPS/50% 
POPC/10% cholesterol;  Lo = 22% DSPC/30% DPPS/23% POPC/25% cholesterol.  The 
histograms represent at least three replicas; error bars show standard deviation. Order 
parameter (S), as determined via ESR, is 0.156 for the Ld composition, and 0.332 for 
the Lo composition.  
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Fig. 3.5  Acyl chain type and presence of cholesterol influence liposome binding 
of purified HIV-1 MA.  Myristoylated MA was purified from an E. coli expression 
system.  Fifteen mg of protein was mixed with 50 mg of liposomes containing either 0% 
cholesterol or 36% cholesterol, or with an Ld or Lo composition, both as defined in Fig. 
4.   Binding was measured after flotation by SDS-PAGE and Coomassie Blue staining 
and densitometry.  A, Representative flotation result showing the stained MA band.  B, 
Quantitation.  For all of these lipid compositions the concentration of PS was constant 
(30%).  Bars represent the average of no less than three replicas. Error bars represent 
standard deviation.  
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Flotation assays were carried out with LUVs prepared with 30% brain PS and egg PC, 
with or without 36% cholesterol, and with or without 2% PI(4,5)P2, a concentration 
similar to that found in HIV-1 virion membranes (3).  In these binding assays, 2% 
PI(4,5)P2 was sufficient to elicit a three-fold increase in Gag binding.  Addition of 
cholesterol boosted Gag binding by a further two-fold (Fig. 3.6). Thus the cholesterol 
enhancement appears to be effective for membrane association driven not only by PS 
alone, but also by PS and PI(4,5)P2, which are inferred to be important in vivo. 
 
SUMMARY AND CONCLUSIONS 
In order to study how virus particles might bud from plasma membrane rafts, we 
set out to develop an in vitro model for HIV-1 Gag binding to raft-like and non-raft-like 
membranes. The results show that Gag-membrane interaction is sensitive not only to 
net negative charge, as known previously, but also to the hydrophobic environment of 
the bilayer, namely cholesterol content and phospholipid acyl chain type.  For example, 
in binary mixtures of PS/PC, the Gag protein strongly prefers DOPS to POPS, and it 
prefers higher over lower cholesterol content in diverse phospholipid mixtures.  
Nevertheless, Gag does not detect membrane order per se, as inferred from 
comparison of Gag binding with membrane order, as measured by ESR. The 
cholesterol enhancement effect behaves as if cholesterol makes more PS available for 
binding to Gag.  To our knowledge, this is the first systematic study of the effects of the 
hydrophobic core of a membrane on the binding of the internal structural protein of an 
enveloped virus.  Although the mechanisms underlying the effects observed appear to  
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Fig. 3.6  Cholesterol enhancement of HIV-1 Gag binding to membranes containing 
PI(4,5)P2.  Gag protein was synthesized and analyzed by flotation as in Fig. 1. White 
bars, binding to liposomes containing 0 or 36% cholesterol (data taken from Fig. 4).  
Grey bars, binding to liposomes with 2% PC being substituted with 2% PI(4,5)P2.  The 
data represent the average of no less than three flotations with error bars representing 
the standard deviations. 
 
 
 
0% PI(4,5)P2
2% PI(4,5)P2
0% Chol 36% Chol
Li
po
so
m
e 
Bi
nd
in
g
(%
 o
f t
ot
al
 G
ag
)
0
80
40
	   	   132	  
	  
	  
	  
be complex, they may be central to understanding the membrane specificity of viral 
budding. 
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CHAPTER 4 
3EFFECT OF MULTIMERIZATION ON MEMBRANE ASSOCIATION OF 
ROUS SARCOMA VIRUS AND HIV-1 MA PROTEINS3 
 
In most retroviruses, plasma membrane (PM) association of the Gag structural 
protein is a critical step in viral assembly, relying in part on interaction between the 
highly basic Gag MA domain and the negatively charged inner leaflet of the PM. 
Assembly is thought to begin with Gag dimerization followed by multimerization, 
resulting in a hexameric lattice. To directly address the role of multimerization in 
membrane binding, we fused the MA domains of Rous sarcoma virus (RSV) and HIV-1 
to the chemically inducible dimerization domain FKBP, or to the hexameric protein 
CcmK4 from cyanobacteria.  The cellular localization of the resulting GFP-tagged 
chimeric proteins was examined by fluorescence imaging, and the association of the 
proteins with liposomes was quantified by flotation in sucrose gradients, following 
synthesis in a reticulocyte extract or as purified proteins.  Four lipid compositions were 
tested, representative of liposomes commonly reported in flotation experiments.  By 
themselves GFP-tagged RSV and HIV-1 MA proteins were largely cytoplasmic, but both 
hexamerized proteins were highly concentrated at the PM.  Dimerization led to partial 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  The following section is reproduced from: Dick, R. A., Kamynina, E., V. M. Vogt. 2013. 
Effect of multimerization on membrane association of Rous sarcoma virus and HIV-1 
MA proteins. (Submitted to J Virol), with modifications to conform to the required format. 
R.A.D. performed liposome flotation, protein purification, and part of the imaging. E.K. 
performed part of the imaging. 	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PM localization for HIV-1 MA.  These in vivo effects of multimerization were 
recapitulated in vitro.  In flotation analyses, the intact RSV and HIV-1 Gag proteins were 
more similar to multimerized MA than to monomeric MA.  RNA is reported to compete 
with acidic liposomes for HIV-1 Gag binding, and thus we also examined the effects of 
RNase treatment or tRNA addition on flotation.  tRNA competed with liposomes in the 
case of some but not all lipid compositions and ionic strengths.  Taken together, our 
results further underpin the model that multimerization is critical for PM association of 
retroviral Gag proteins. 
 
INTRODUCTION 
      Particle assembly and budding are critical steps in the retrovirus life cycle.  For 
most retroviruses the structural protein, Gag, assembles into a budding virus particle on 
the inner leaflet of the cellular plasma membrane (PM). The matrix domain (MA) at the 
N-terminus of Gag mediates the PM interaction. Retroviral MAs contain as many as 
three membrane binding signals that provide membrane interactions as well as 
specificity. First, all contain a highly basic region that interacts electrostatically with the 
negatively charged inner leaflet of the PM (55). The inner leaflet of the PM derives its 
net negative charge from phosphatidylserine (PS) and to a lesser extent 
phosphatidylinositols (PIPs) (83). Second, most retroviral MAs are myristoylated, a 
modification that is required for membrane interaction (71). However, the Gag proteins 
of some retroviruses, such as Rous sarcoma virus (RSV) and equine infectious anemia 
virus (EIAV), are not myristoylated.  
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      Third, at least some retroviral MAs have phosphatidylinositol (4,5) bisphosphate 
(PI(4,5)P2) binding pockets.  Examples include human immunodeficiency virus type-1 
and type-2 (HIV-1, HIV-2), Mason-Pfizer monkey virus (MPMV), and EIAV.  Other 
viruses, RSV, murine leukemia virus (MLV), and human T-lymphotropic virus (HTLV) 
apparently do not (31, 66, 73, 74). In vivo, HIV-1 and MLV are sensitive to 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) depletion mediated by 5PtaseIV, in 
that plasma membrane localization and viral particle release are decreased (13, 15, 39, 
41, 58). HTLV and EIAV are less sensitive to PI(4,5)P2 depletion (31, 41). However, 
EIAV virus-like particle (VLP) release is decreased by expression of synaptojanin 2, a 
phosphatase with broad specificity (31). In vivo, RSV does not respond to 5PtaseIV 
depletion under conditions that HIV-1 does (13), but under different conditions RSV Gag 
also is sensitive to 5PtaseIV (56).  
 In contrast with some in vivo results, in liposome binding assays in vitro most or 
all retroviral Gag proteins bind more tightly to membranes in the presence of PI(4,5)P2 
as well as other PIPs (13, 16, 18, 27, 39).  In such assays it is challenging to ascertain 
to what degree PIP-enhanced binding is due to electrostatic interactions, and to what 
degree it is due to specific recognition of the PIP head group.  In solution with short 
chain versions of PI(4,5)P2, HIV-1 MA interacts not only with the phosphorylated inositol 
head group but also with the 2ʼ acyl chain (74). This observation led to a model for HIV-
1 MA and Gag in vivo, in which the typically unsaturated, long 2ʼ acyl chain “flips out” of 
the hydrophobic core of the lipid bilayer and binds instead to a hydrophobic groove in 
MA (34, 74). Similar observations recently have been reported for short chain versions 
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of the abundant inner leaflet phospholipids PS and phosphatidylcholine (PC) (84).  
Recently we demonstrated that HIV-1 Gag binding to liposomes is strongly modulated 
by membrane cholesterol content and by degree of acyl chain unsaturation, implying 
that the protein can somehow sense the hydrophobic environment of the membrane 
(27).  
Assembly of the virus particle is driven by Gag-Gag interactions, ultimately 
resulting in the formation of an incomplete hexameric lattice in the immature virus 
particle just before its release from the cell (5, 85). Gag multimerization primarily is 
dependent on interactions of the capsid (CA) portion of Gag, plus short immediately 
adjoining N-terminal and C-terminal sequences (26, 45, 48, 64).  The CA-CA contacts 
that hold the immature Gag lattice together have not been elucidated at a molecular 
level, although an 8A model recently has been suggested based on electron cryo-
tomographic reconstructions of the MPMV lattice (3).   It is unknown if Gag hexamers 
form in the cytoplasm and are an intermediate in assembly, or alternatively if the 
hexameric lattice grows by addition of monomers or dimers.   
      Gag dimers are inferred to be a critical building block of the Gag lattice, as 
evidenced by diverse studies.  For example, in vitro assembly requires a nucleic acid 
(such as a DNA oligonucleotide) that is long enough to bind to two NC domains, or 
about 16 nt in the case of RSV (53, 54, 86).  The function of NC can be replaced by a 
coiled coil domain that forms dimers (leucine zipper) (1, 2, 19, 42, 87), and in some 
cases disulfide-mediated crosslinking near the Gag C-terminus also can replace NC (2).  
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 While the role of Gag multimerization in particle assembly has been studied 
extensively, little is known about how multimerization affects Gag membrane binding. 
While MA is dispensable for assembly of particles in vitro (10-12, 37), in vivo assembly 
of Gag at the PM requires a membrane binding domain--either its own MA or part of it 
(16, 63), or the MA from another retrovirus (14, 41, 62, 69), or a membrane binding 
domain from a cellular protein (13, 43, 82). In an extreme example, a deletion of Gag 
MA that removed the entire highly basic region (HBR) including the PI(4,5)P2 binding 
pocket, but left the N-terminal myristoylation site, only modestly reduced the number of 
released extracellular particles (4, 70). By contrast, a Gag mutation that prevented 
myristoylation abrogated membrane binding and VLP release, although some particles 
were assembled in the cytoplasm (57). In summary, while a membrane binding domain 
is not required for Gag assembly it is required for targeted assembly at the PM of cells. 
 Both RSV and HIV-1 Gag MA domains can interact with RNA (38, 40, 52, 61, 67, 
68, 80).  At least in HIV-1, MA-RNA interaction can regulate membrane binding (18).  In 
this example, the RNA binding appeared not to be dependent on the overall electrostatic 
charge of MA, but instead on two lysine residues located near the PI(4,5)P2 binding 
pocket. When these two amino acids were mutated, MA membrane binding became 
promiscuous, resulting in an increase in particle release in vivo (18).  RSV MA binds 
RNA much more weakly than does HIV-1 MA (K. Musier-Forsyth, personal 
communication), and hence any role that RNA may play in Gag membrane binding in 
vivo may not be common to all retroviruses. 
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 Little is known about the interplay between Gag-membrane interaction and Gag-
Gag interactions.  Previously we showed that dimerization of RSV MA and HIV-1 MA 
increases membrane binding by an order of magnitude (20, 21).  We have now 
expanded on this observation with in vivo and in vitro assays of MA proteins that were 
engineered to be monomeric, dimeric, or hexameric.  We have also investigated the 
effect RNA has on the binding of RSV and HIV-1 Gag to membranes in vitro. Overall, 
the results show that while MA dimerization is sufficient to increase membrane binding 
under some conditions, the increase is most dramatic upon MA hexamerization. 
 
MATERIALS AND METHODS 
DNA vectors 
The MA multimers used in this study are shown schematically in Fig. 4.1. All DNA 
constructs were cloned using common subcloning techniques and were propagated in 
DH5a cells. RSV and HIV-1 MA were PCR amplified and ligated at an AatII restriction 
site (added with primers) to either FKBP (Clontech) or Ccmk4 with a DVGSGS or 
DVTRPEL linker, respectively. The Ccmk4 plasmid was a gift from Owen Pornillos (65). 
RSV and HIV-1 MA–FKBP and MA–Ccmk4 fusion proteins were PCR amplified and 
cloned into pET3x for reticulocyte expression using sites NdeI and KpnI (in the 
backbone of the vector and added to the MA chimeras by PCR). The same chimeras 
were fluorescently tagged by cloning into pEGFP-N1 (Clontech) using sites EcoRI and 
AgeI (in the backbone of the vector and added to the insert by PCR). RSV MA and 
super M-MA (SM-MA) were cloned into pET3x and pEGFP in the same way. The  
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Fig. 4.1  Schematic representations of proteins. RSV and HIV-1 proteins (top and 
bottom) used in liposome flotation assays. GFP-tagged versions of the proteins 
expressed in transfected cells are denoted by GFP in parenthesis. All HIV-1 proteins 
used were myristoylated, as denoted by the line at the N-terminus. The mutations E25K 
and E70K of Super-M (SM) RSV MA are shown by an asterisk. 	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plasmid expressing HIV-1 MA (myr-MA) was previously described (21, 81). RSV 
GagΔPR and HIV-1 GagΔP6  (henceforth referred to as RSV Gag and HIV-1 Gag) were 
previously described in (13). Super M Gag was a gift from John Wills (9). 
Cells, transfection, and imaging 
Cell cultures and transfections were performed as previously described (13, 21). 
QTC (quail) fibroblasts were maintained in Dulbecco modified Eagle medium 
supplemented with 5% fetal bovine serum, 5% NuSerum (BD Biosciences), 1% heat-
inactivated chick serum, standard vitamins, L-glutamine, penicillin, and streptomycin.  In 
brief, QT6 cells were seeded onto glass coverslips 24 h prior to transfection. At 50% 
confluence cells were transfected with 1ug of DNA per mL of medium with FuGENE HD 
(Roche) according to the manufacturerʼs instructions. For cells expressing MA-FKBP-
GFP, medium was replaced 16-18 h post transfection with medium with (dimer) or 
without (monomer) 100 nM homodimerization reagent AP20187 (BB) (Clontech).  
Cells were imaged as previously described (13).  Briefly, at 20-24 h post 
transfection cells were fixed with 3.7% formaldehyde in PBS for 15 min and mounted on 
glass slides with Fluoro-Gel (Electron Microscopy Sciences). Slides were viewed on an 
Ultraview spinning disc confocal microscope (Perkin-Elmer) with a Nikon 100x Plan-
Apochromat oil objective lens. Image analysis was performed using ImageJ software 
(v1.40g). The strength of fluorescence at the plasma membrane and the cytoplasm was 
measured at two or three representative locations for each cell using the plot profile 
function. Cells with low and high expression levels were included. Background was 
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subtracted and the ratio of plasma membrane to cytoplasmic signal was quantified. 
Outliers were identified and removed using the Q test.  
Liposome binding and velocity sedimentation 
Large unilamellar vesicles (LUVs) were prepared by the rapid solvent exchange 
(RSE) method as previously described (6, 27, 88). Briefly, lipids in chloroform were 
mixed in glass tubes at the stated molar ratios. Excess chloroform was removed by 
evaporation under a stream of nitrogen to a final approximate volume of 50 uL. Buffer 
(20 mM HEPES, pH 7.0) was added and the mixture was vortexed under vacuum for 90 
seconds and sealed under argon gas, resulting in a final hydrated lipid mixture at 
10mg/mL. LUVs were prepared by extruding the lipid mixture at least 41 times through a 
100 nm polycarbonate filter (Avanti) on a mini-extruder block heated to 45 °C. LUVs 
were used within 10 days of preparation.  
  LUV binding was performed as previously described (13, 15, 20, 21, 27). Briefly, 
radioactively labeled protein was prepared by translation in the TNT coupled T7 rabbit 
reticulocyte reaction (Promega) in the presence of  [35S]methionine/cysteine (Perkin-
Elmer; ExPRE35S35 protein labeling mix). Five uL of reticulocyte reaction was 
combined with 15 uL binding buffer (20mM HEPES pH 7.0) and 50 ug LUVs (to a 
concentration of 8.5 mg/mL). The reaction mix was incubated for 10 minutes at 22 °C. 
The reaction mix was than combined with 75 uL 67% sucrose (20mM HEPES pH 7.0). 
Next, 80 uL of the resulting sucrose and reaction mix was placed in a TLA-100 tube 
followed by 120 uL 40% sucrose and 40 uL 4% sucrose. All sucrose was made wt/wt 
with binding buffer. Centrifugation was performed at 90,000 rpm in a TLA-100 rotor 
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(Beckman) for one hour. Purified protein flotations were performed with 10 ug of protein 
in place of the reticulocyte reaction. The binding buffer and sucrose were supplemented 
with NaCl to a final concentration of 50 mM or 150 mM. 
 Velocity sedimentation was performed with an eight-step sucrose gradient (20 
mM Tris pH 8.0 and 150 mM NaCl), 10-30% (wt/wt), overlaid with approximately 50 ug 
purified protein in storage buffer (20mM Tris pH 8.0, 150-350mM NaCl, 30% glycerol, 
10mM DTT). Gradients were centrifuged in a SW-60 (Beckman) rotor at 45,000 rpm for 
20 h. Fourteen, 270 uL fractions were taken and 40 uL of each was subjected to SDS-
PAGE on a 17.5% SDS gel. Gels were Coomassie stained for 16 h, destained, and 
imaged.  
 Protein purification 
Proteins were purified as previously described (20, 21, 27) with some 
modifications. Briefly, BL21 cultures were grown to an OD600 of 0.4, IPTG was added 
to a final concentration of 0.5 mM, and cells were collected 4 h later. Pelleted cells were 
resuspended in lysis buffer (20 mM TrisHCl pH 8.0, 500 mM NaCl, 10 mM DTT, 
protease inhibitor (Roche, Complete Mini tablet)), lysed by sonication, and cleared by 
centrifugation in a TLA-110 (Beckman) rotor at 90K for 45 min. Polyethylenimine (PEI) 
was added to a final concentration of 0.3% to precipitate nucleic acid, which was spun 
down and removed. Ammonium sulfate was added to 30% saturation to precipitate the 
protein, followed by centrifugation. The pellet was resuspended in binding buffer (20 mM 
Tris pH 8.0, 100 mM NaCl, 10 mM DTT). The protein was further purified by cation 
exchange chromatography (HiTrap SP, Amersham Pharmacia). All purified proteins 
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were concentrated to 2-5 mg/mL (Millipore, Ultracel -10K), aliquoted, and stored at -80 
°C in storage buffer (10-20mM Tris pH 8.0, 150-330 mM NaCl, 10mM DTT, 30% 
Glycerol). HIV-1 MA (myr-MA) was purified as described (21, 27, 81). BL21 cultures 
were supplemented with myristic acid (10 mg/L, Sigma) 1 h before induction with IPTG. 
The MA protein was purified from the supernatant by Ni-NTA resin (Qiagen) followed by 
cation exchange chromatography (HiTrap SP, Amersham Pharmacia). Mass 
spectrometry confirmed that the protein was myristoylated.  
 
RESULTS 
We examined the effect of MA dimerization and hexamerization on membrane 
interaction in vivo and vitro. Chimeric MA proteins that can be induced to dimerize were 
created by fusion of MA with the FK506-binding protein (FKBP) (44, 72, 76) (Fig. 4.1).  
Similarly, hexameric MAs were created by fusion with the cyanobacterial carboxysome 
shell protein Ccmk4 (46, 65). The chimeras were designed so that the MA moieties are 
oriented with their membrane-binding domains all facing in the same direction, similar to 
their arrangement in the Gag lattice. For in vivo visualization, the chimeras were further 
fused to GFP (Fig. 4.1). MA dimers and hexamers were compared with MA monomers 
and with full length Gag in a standard liposome (also referred to as large unilamellar 
vesicle, LUV) flotation assay, using radiolabeled proteins generated in a reticulocyte 
extract, or in some cases using purified proteins.  
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Effect of MA dimerization and hexamerization on sub-cellular localization 
Reports of HIV-1 MA cellular localization vary from cytoplasmic (21, 28, 59, 60) to 
partially membrane associated (77, 89), while fluorescence of RSV MA-GFP is 
cytoplasmic and nuclear (75) owing to a nuclear localization signal (NLS) in the latter (7, 
75).  To determine the effect of dimerization on cellular localization of MA, we treated 
transfected cells expressing chimeric MA proteins with the dimerization chemical 
AP20187 (here referred to as BB). The amount of BB required to induce a change in 
MA-FKBP localization was determined empirically in a series of concentration tests 
(data not shown).  
The fluorescence from RSV MA-GFP and MA-FKBP-GFP monomers (-BB) were 
cytoplasmic and nuclear, as expected (Fig. 4.2A) (75).  Inducing dimerization (+BB) did 
not significantly affect this result.  By contrast, the RSV MA-Ccmk4-GFP hexamer was 
strongly concentrated at the PM, with little fluorescence elsewhere in the cell.  To 
provide a graphical representation of the images, we used the ImageJ plot profile 
function to count pixel intensity, which is correlated with the fluorescence signal, at the 
plasma membrane and in the cytoplasm for each chimera tested. Over thirty cells were 
analyzed for each chimera, with at least two measurements per cell. Ratios of the 
average fluorescence intensity at the PM and cytoplasm showed that for the RSV MA 
chimeras, hexamerization increased PM localization by approximately five-fold over the 
monomers and dimers (Fig. 4.2B).  
For HIV-1, monomeric MA-FKBP-GFP was cytoplasmic while the dimerized MA-
FKBP-GFP (+BB) was enriched somewhat at the PM. Similar to RSV MA-Ccmk4-GFP,  
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Fig. 4.2  Effect of multimerization on RSV and HIV-1 MA-GFP localization. 
(A) QT6 cells were transfected with DNAs for either RSV (left) or HIV-1 (right) 
GFP-tagged MA multimers. MA or MA chimeras are indicated on far left as MA 
(monomer, triangle), MA-FKBP (monomer, minus), MA-FKBP +BB (dimerized, 
plus), and MA-Ccmk4 (hexamer, hexagon). Images are of a single confocal 
section near the mid-body of cells. Images are representative for each protein 
(n>25). (B) Ratio of plasma membrane to cytoplasmic fluorescent signal. For 
each cell at least two measurements of signal intensity, at representative 
locations, were taken as described in Materials and Methods, for a total of at 
least 50 measurements per protein. P values were determined using Studentʼs 
t test for comparisons denoted by horizontal line above two bars. Asterisk 
indicates  P<0.001. 	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the HIV-1 MA-Ccmk4-GFP hexamer was very strongly concentrated at the PM (Fig. 
4.2A, B). These results for both viruses suggest that for the full length Gag protein, 
stable binding to the PM most likely requires multimerization. For HIV-1, dimerization 
may be sufficient to drive Gag to the PM but for RSV dimerization is not sufficient.  
 To investigate the possible cell-type specificity of the effects of hexamerization, 
both RSV and HIV-1 MA-Ccmk4-GFP localization were tested in 293T cells, yielding the 
same results as observed in QT6 cells (data not shown).  As a further control to rule out 
the possibility that Ccmk4 itself might interact with membranes, we visualized the 
localization of Ccmk4-GFP.  The fluorescence was diffuse and cytoplasmic (data not 
shown).  
Effect of MA dimerization and hexamerization on liposome interaction 
We previously reported that dimerization of purified RSV and HIV-1 MA results in 
an increase in LUV association across a range of lipid concentrations (20, 21).  In those 
studies dimerization was achieved by fusing the MA domain to either a monomeric 
(mutant W184A/M185A, (35) or a dimeric (Q192A, (25)) version of the HIV-1 CA C-
terminal domain (CACTD). In transfected cells, the GFP-tagged HIV-1 MACACTD(Q192A) 
was somewhat concentrated at the PM in 293T cells (21), while the similarly constructed 
RSV dimer was largely cytoplasmic in avian DF-1 cells (unpublished results), fully 
consistent with the present results based on FKBP chimera. We re-tested both of the 
CACTD chimeras in 293T cells and again observed similar localization. However, when 
these monomeric and dimeric proteins were translated in vitro in a rabbit reticulocyte 
system and subjected to liposome flotation, the proteins did not behave as reported 
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previously for the purified proteins.  Little difference in flotation between monomeric and 
dimeric MAs was observed, both for RSV MACACTD and HIV-1 MACACTD (data not 
shown). By comparison with other proteins, we infer that the reticulocyte-generated 
MACACTD(W184A/M185A) monomers behave like dimers.  Apparently some component in 
the reticulocyte system affects dimerization or membrane binding for these chimeric 
proteins.   
To address this discrepancy, we employed an independent approach to study the 
effect of MA dimerization, based on the chemically inducible dimerization domain FKBP 
(44, 79).  When RSV MA by itself and monomeric RSV MA-FKBP were compared, 
similar flotation results were obtained for all LUV types tested, implying that in this 
assay MA and MA-FKBP in the absence of BB are functionally equivalent.  Similar to 
the approach used in vivo, a series of flotations was carried out to find the optimal 
homodimerization reagent concentration to elicit dimerization of MA-FKBP, as 
measured by augmented liposome flotation (data not shown).  BB-induced dimerization 
led to a two- to three-fold increase in flotation of RSV MA-FKBP (Fig. 4.3A, B), and up to 
a two-fold increase for HIV-1 MA-FKBP (Fig. 4.3A, C).  For the hexamerized MA-CcmK4 
chimeras, association with liposomes was three- to five-fold higher than for the 
monomeric protein for RSV, and about two-fold higher for HIV-1.  In summary, though 
differing in detail, LUV binding of these chimeric monomeric, dimeric, and hexameric MA 
species to four types of LUVs followed the same trends as observed in cells. 
 We also compared flotation of full-length RSV and HIV-1 Gag proteins with 
flotation of the chimeric MA species. Previous work by us and by others had shown that  
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Fig. 4.3  Flotation analysis of RSV and HIV-1 MA multimers. Liposomes 
were made with the following compositions PC/PS (70/30), PC/PS (40/60), 
PC/PS/Chol (34/30/36), or PC/PS/PI(4,5)P2 (68/30/2). All proteins were 
radiolabeled in reticulocyte translation reactions. (A) Representative flotation 
results of MA multimers to PC/PS/Chol liposomes. Symbols denoting 
multimeric state, the same as Fig. 2.  The radioactive protein was scored 
either as membrane-bound (MB) or non membrane-bound (NMB). (B and C) 
Percent of total protein found associated with liposomes for both RSV and 
HIV-1 MA multimers. Error bars represent standard deviations from the mean. 
P values for Studentʼs t test for comparison of MA-FKBP monomer to MA-
FKBP dimer, MA-Ccmk4 hexamer, and Gag (*, P<0.05; **, P<0.005). 	  
	   	   154	  
	  
	  
	  
Gag binding to liposome membranes is augmented by high concentrations of PS, by 
cholesterol, and by low concentrations of PIPs (13, 16, 27).  These findings were 
qualitatively recapitulated in the present study (Fig. 4.3).  In comparisons of Gag with 
the different MA multimers, Gag behaved like the MA multimers, but with some 
variation.  For example, flotation of HIV-1 Gag with LUVs made with low PS was 
consistently not higher than flotation of monomeric MA (Fig. 4.3C).   Also, flotation of the 
RSV MA-FKBP monomer was not boosted by cholesterol or PIP2, and similarly flotation 
of the HIV-1 MA-FKBP monomer was not boosted by PIP2.  To explain these results, 
we speculate that the observed high binding of Gag to LUVs with cholesterol or PIPs 
may reflect Gag multimerization. Expressed in another way, membranes that support 
strong binding of Gag may promote Gag multimerization. 
Membrane association of purified MA multimers 
To further investigate the effect of MA multimerization on membrane association, 
we purified RSV MA, RSV MA-FKBP, RSV MA-Ccmk4, and HIV-1 myr-MA after 
expression in E. coli. First, to confirm that these proteins were in their predicted 
multimeric state, sucrose gradient velocity sedimentation was performed. Each protein 
traveled to a fraction consistent with its predicted size, based on the assumption that the 
proteins are roughly globular (Fig. 4.4A). Second, the proteins were submitted to 
flotation analyses like those for radioactive proteins translated in vitro. The LUV binding 
was in agreement with that found for the reticulocyte-translated proteins.  For example, 
the RSV MA-Ccmk4 hexamer associated with all liposome types significantly more than 
did the MA-FKBP monomer (Fig. 4.4B).   Similarly, LUV association of the RSV MA  
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Fig. 4.4  Flotation analysis of purified RSV MA multimers. (A) Velocity 
sedimentation of RSV MA, MA-FKBP, MA-FKBP +BB, and MA-Ccmk4 proteins. A 
molecular weight marker is indicated for the MA and MA-FKBP gels; all other gels were 
run identically.  Dotted lines are added to more easily show the shift of MA monomers to 
dimer and hexamer. (B) Percent of total protein found associated with four liposome 
types. Symbols indicate protein type, as in Fig. 2. All MA proteins are RSV except HIV-1 
myr-MA, which is indicated by the black triangle. Error bars represent standard 
deviations from the mean. 
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monomer, dimer, and hexamer was strengthened by high PS, by cholesterol, and by 
PIP2, as found for the in vitro translated proteins. We conclude that the effects of 
multimerization and of membrane composition on membrane binding are not 
substantially altered by the vast excess of rabbit protein present in the in vitro 
translation mix. 
 Previously we reported that the relative binding constants of monomeric RSV 
MACActd and monomeric HIV-1 MACActd were of similar magnitude, and the same for 
the dimeric versions of these proteins (20, 21).  In contrast, in the present study RSV 
MA and MA-FKBP on the one hand, and HIV-1 myr-MA on the other, showed significant 
differences in the flotation. Perhaps this discrepancy arises from the different salt 
concentrations used in the analyses, 75mM NaCl in the earlier work (20, 21) and 
150mM NaCl here. 
Effect of RNA on Gag and MA membrane interaction 
RNase treatment of a reticulocyte extract in which HIV-1 Gag has been 
synthesized increases Gag binding to liposomes, suggesting that RNA competes for 
Gag-membrane interactions (18). To determine if this is a general principle of retroviral 
Gag- and MA-membrane interaction, we tested the effect of RNase on RSV MA 
monomer and RSV Gag, compared with HIV-1 MA-FKBP monomer and HIV-1 Gag. 
RNase treatment for RSV MA, MA-FKBP monomer, and Gag had little effect on 
membrane binding of these proteins. Enhanced binding was observed only for RSV MA 
monomers to LUVs with high levels of PS (Fig. 4.5A). By contrast, the LUV binding of 
HIV-1 MA-FKBP monomer and of HIV-1 Gag was augmented by RNase treatment (Fig.  
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Fig. 4.5  Effect of RNA on liposome binding of reticulocyte-generated RSV MA or 
RSV Gag.  (A, B) Liposome binding of RSV and HIV-1 MA (triangle, not done for HIV-1), 
MA-FKBP monomer (dash), and Gag (circle) protein to liposomes in the absence of 
(light gray) or presence of (dark gray) RNase. Error bars represent standard deviations 
from the mean. 
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4.5B), as reported previously (18, 41). At low PS, the flotation levels for the HIV-1 
proteins increased by about three-fold. At high PS and with the addition of cholesterol, 
flotation of HIV-1 MA-FKBP monomer increased about two-fold, but of HIV-1 Gag 
increased only modestly. The small effect of RNase on HIV-1 Gag for these lipid 
mixtures might be explained by saturation of binding.  In our hands, RNase also led to 
about a two-fold stimulation of flotation of HIV-1 MA-FKBP monomer and of HIV-1 Gag 
to PIP2-containing liposomes, in contrast to the results of Chukkapalli et al (18), who 
saw no increase in the presence of PIP2.  This discrepancy might be grounded in 
differences in PIP concentrations. We used a more physiological 2% PIP2 compared 
with their 7%. In summary, these results suggest that at equivalent protein, salt, and 
lipid concentrations, RNA does not inhibit the LUV binding of RSV MA and Gag, while it 
does inhibit LUV binding of HIV-1 MA and Gag. 
 RSV MA has a net surface charge of plus three, while HIV-1 MA has net surface 
charge of plus six (55). We speculated that this difference might underlie the observed 
differences in RNase sensitivity.  To explore this idea, we tested the binding of a mutant 
RSV MA called super-M (SM) to liposomes, with and without RNase treatment.  SM-MA 
carries the two mutations E25K and E70K (8, 9), resulting in a net change in charge of 
plus four, leading to a total surface charge of plus seven.  SM-Gag is known to bind 
more rapidly to the PM, and as a consequence to bypass trafficking into the nucleus (8, 
9).  SM-MA floated with LUVs approximately two-fold more extensively than did wt MA 
when the liposomes had low levels of PS or included cholesterol or included PIP2 (Fig. 
4.6). Similar to what was observed for HIV-1 MA-FKBP, RNase increased the binding of  
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Fig. 4.6  Effect of RNase on Super-M  MA. Liposome binding of RSV SM MA to 
liposomes without (light gray) or with (dark gray) RNase. Error bars represent standard 
deviations from the mean. 
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SM-MA to three of the four LUV types tested.  From these results taken together, we 
conclude that in this experimental setting RNA plays less of a role in membrane 
interaction for wt RSV than for HIV-1, and that this difference is accounted for at least in 
part by surface charge density. 
RNA - membrane competition with purified RSV MA and HIV-1 MA 
Considering the basic nature of both RSV and HIV-1 MA, it seemed surprising 
that RNase treatment of the reticulocyte extract led to different results for the wt RSV 
and HIV-1 proteins.  Therefore, we decided to test for RNA competition in another way, 
using flotation analysis of purified RSV MA and HIV-1 myr-MA proteins in the presence 
or absence of added purified tRNA.  At 150mM NaCl little or no tRNA effect on flotation 
of either protein was observed (data not shown). But at 50 mM NaCl, consistent with 
flotations of RNase-treated reticulocyte translation reactions, addition of tRNA 
decreased the binding of HIV myr-MA to all LUVs tested (Fig. 4.7B). This decrease was 
greatest for membranes with low levels of PS. For RSV MA at this salt concentration, 
addition of tRNA also led to greatly reduced flotation for LUVs with low levels of PS.  But 
unlike for HIV-1 myr-MA, for RSV MA the addition of tRNA did not significantly reduce 
binding to LUVs with PIP2. The effect of tRNA on protein binding to LUVs prepared with 
high levels of PS or cholesterol was modest for both HIV-1 and RSV MA. These results 
suggest that RSV MA binding to membranes with high PS, with cholesterol, or with 2% 
PIP2 is hardly perturbed by tRNA.  
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Fig. 4.7  RNA inhibition of purified RSV and HIV-1 MA proteins. (A, B) Liposome 
binding of purified RSV man and HIV-1 myr-MA proteins to liposomes in the absence 
(light gray) or presence (dark gray) of tRNA. Error bars represent standard deviations 
from the mean.  	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DISCUSSION  
We have studied the effect of multimerization on the binding of RSV and HIV-1 
MA to membranes in vivo and vitro.  For HIV-1, dimerization of MA-GFP increased 
fluorescence at the PM, as reported previously (21), while hexamerization led to highly 
concentrated PM fluorescence. For RSV, dimerization of MA-GFP did not lead to 
significant PM localization, but hexamerization resulted in highly concentrated PM 
fluorescence, as for HIV-1.  Liposome flotation analyses of MA multimers translated in 
vitro in a reticulocyte extract largely mirrored what was observed in transfected cells.  
For both viruses, binding of full length Gag protein to liposomes resembled binding by 
dimeric or hexameric MA.  In their interactions with liposomes, RSV and HIV-1 MA 
proteins in the reticulocyte translation mixes differed in their response to RNase 
treatment.   As had been shown previously for HIV-1 Gag (18), RNase increased the 
flotation of HIV-1 Gag and MA-FKBP, but had little effect on RSV Gag, MA, and MA-
FKBP.   
In previous work on binding of full length Gag to liposomes (13, 15, 27), it was 
assumed, explicitly or tacitly, that Gag remained monomeric, since the Gag 
concentration in the reticulocyte extract was presumed to be below the Kd for 
dimerization (~10 uM,(35)).  Two scenarios could explain our present results showing 
that by liposome flotation both HIV-1 and RSV Gag behave more like MA multimers 
than MA monomers.  The first is based on the presence of two highly basic domains in 
Gag, MA and NC, both of which may interact with membranes.  Indeed it is known for 
HIV-1 Gag (in its non-myristoylated form) that in solution the MA and NC domains are 
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near each other, making the overall shape of Gag like that of a horseshoe (22, 23). 
Moreover, from low angle neutron scattering analyses of HIV-1 Gag bound to a tethered 
membrane, it appears that the horseshoe shape is maintained, implying that both 
domains contact the membrane simultaneously under the relatively low ionic strength 
conditions used (23).  One domain, presumably NC, can be displaced by addition of 
nucleic acid or by increase of the ionic strength, leading to an extended Gag 
conformation.  Perhaps related to these observations, HIV-1 NC appears to play a role 
in localizing Gag to virological synapses in uropods (51). On the other hand, the 
possible function of HIV-1 NC in membrane binding is called into question by the 
observation that wt Gag and Gag missing the NC domain bind similarly to PC/PS 
liposomes (18).  
 The second possible explanation to account for the similarity of liposome binding 
by Gag and multimeric MA is that Gag multimerization is promoted by the RNA in the 
reticulocyte extract, and/or by membranes.   For example, in preliminary experiments 
we confirmed earlier reports that after ultracentrifugation much of HIV-1 Gag was in the 
pellet, even in the absence of added liposomes (78). By contrast, under the same 
conditions, most of the RSV Gag remained in the supernatant.  To address the 
questions implied by these observations, it will be important to carefully compare the 
properties of purified Gag with the properties of in vitro-translated Gag in crude extracts.   
Comparisons and quantitative interpretations of the various published liposome 
binding experiments with Gag proteins, including the flotation experiments described 
here, is hampered by the diversity of experimental conditions used in different labs and 
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even the same lab.  For example, the ionic strength in the liposome-Gag mix before 
centrifugation as well as in the sucrose gradients has not been constant for the several 
published papers.  Nor have the methods for liposome preparation and for centrifugation 
been identical.  In our own work presented here, to facilitate processing of the large 
number of flotation experiments analyzed, we used very small (0.25mL) sucrose 
gradients, similar to those described by Dalton et al (20, 21, 27).  In an earlier 
publication we used 4 mL gradients and longer centrifugation times, which may explain 
why some of the results are quantitatively, though not qualitatively, different.  It would be 
very useful to develop a liposome binding assay that is more rapid and quantitative than 
flotation, and that has a greater dynamic range. 
 Both in vivo (13, 16, 18, 39, 41, 56) and in vitro (13, 16, 17, 27, 39, 41, 73, 74) 
PIPs stimulate PM interaction of retroviral Gag or MA proteins, but these several 
observations are difficult to interpret in a unified manner. For example, on the one hand 
the specificity of the HIV-1 MA binding pocket for short chain PI(4,5)P2 is well 
established (74), and depletion of PI(4,5)P2, the major PIP species at the PM, 
compromises HIV-1 Gag PM association (13, 16, 41).  But on the other hand, HIV-1 
Gag shows only very modest specificity for PI(4,5)P2 by flotation analysis (13, 16).  It 
remains to be established to what degree PIP stimulation of membrane binding in vitro 
is due only to electrostatics.   
In the experiments described here, we observed that the addition of 2% 
PI(4,5)P2 to liposomes enhanced binding of HIV-1 Gag more than it did the binding of 
monomeric or the multimeric chimeric species of MA.  To explain this effect, we 
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speculate that PI(4,5)P2 promotes multimerization of HIV-1 Gag.  This hypothesis is 
based in part on the effects of the PIP head group analogs on in vitro assembly of HIV-1 
Gag.  A non-myristoylated, MA-deleted version of Gag (missing residues 16-99) 
assembles into normal immature particles in the presence of nucleic acid (10).  
However, full length non-myristoylated HIV-1 Gag assembles into tiny aberrant particles.  
This defect can be corrected by addition of inositol hexakisphosphate (IP6) or IP5 (10).  
Tight interaction of IP6 with Gag requires both the MA and NC domains (24), and this 
interaction appears to promote a Gag monomer-trimer equilibrium.  The authors of 
these studies interpreted the action of IP6 or IP5 in this in vitro system to mimic PIPs, 
perhaps PI(4,5)P2 or PI(3,4,5)P2.  The hypothesis that PIP enhancement of liposome 
binding at least in part reflects a stimulation of Gag multimerization remains to be 
tested.    
HIV-1 Gag binding to membranes in vitro is modulated by nucleic acid. Depletion 
of RNA from reticulocyte reactions by RNase treatment, or by mutation of the two lysine 
residues in MA that are inferred to be RNA binding residues (18), results in enhanced 
flotation (17, 18, 41). We have extended the study of this RNase effect to the chimeric 
HIV-1 MA species and to RSV.  It seems surprising that in contrast to HIV-1 Gag and 
MA, RSV Gag and the chimeric RSV MA species hardly respond to RNase treatment of 
the reticulocyte lysate.  The simplest explanation of these differences between the two 
viruses is based on the observation that the interaction of RSV MA with RNA is much 
weaker than that of HIV MA (K. Musier-Forsythe, personal communication). These 
differences may be grounded in part in the different surface potential of the MA domain, 
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with HIV-1 MA having a net positive surface charge of +6 compared with +3 for RSV MA 
(55).  The importance of surface charge in this context is suggested by the observation 
that the super M mutant form of RSV MA, with a surface charge of +7, was similar to 
HIV-1 MA in the effect of RNase treatment on liposome flotation.  Alternatively or in 
addition, HIV-1 MA has been inferred to have a specific RNA binding surface that 
requires specific lysine residues (18), which might be absent in RSV, even though RSV 
MA also can bind to RNA (80).  It remains challenging to understand how RSV Gag is 
targeted to the PM despite both a lesser surface charge and a lack of myristoylation.  
We hypothesize that while both RSV and HIV-1 rely on multimerization for stable PM 
interaction, RSV requires higher order multimerization than does HIV-1. 
For all retroviruses surprisingly little is known about the multimeric state of Gag 
between the time it is synthesized as a monomer on cytoplasmic polysomes and the 
time it becomes associated with a budding virus particle at the PM.  Prior to assembly, 
HIV-1 Gag becomes complexed with cellular proteins, for example ABCE1 (also called 
HP68) (30, 47) or AP3 (29), and RSV Gag may enter similar complexes (50), but the 
stoichiometry of Gag molecules in these structures has not been established.  In order 
to understand the mechanism of assembly, it will be important to determine the 
multimeric status of retroviral Gag proteins before they reach the plasma membrane.  
Two studies have addressed this issue.  Based on in vivo crosslinking, Kutluay et al (49) 
concluded that the most abundant HIV-1 species in the cytoplasm is monomeric.  
Fogarty et al (32) came to a similar conclusion using multiphoton microscopy coupled 
with quantitative fluorescence fluctuation analysis of Gag-GFP (33, 36).  With this 
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technology it is possible to estimate the actual molar concentration of Gag-GFP in the 
cystoplasm.  In that experimental setting, PM binding of HIV-1 Gag-GFP as well as 
limited multimeric forms of Gag were observed only after the cytoplasmic concentration 
reached a critical concentration, approaching micromolar (Lou Mansky, personal 
communication).  What these techniques are not able to answer unambiguously is 
whether Gag multimers that form in the cytoplasm then quickly become PM-bound, or 
alternatively Gag molecules are recruited as monomers to assembly sites on the PM.  
More sophisticated dynamic analyses will be needed to address these questions. 
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CHAPTER 5 
PERSPECTIVES 
My work, and the work of many others, has identified key principles involved in 
the binding of Gag to the inner leaflet of the plasma membrane. These principles include 
electrostatics, fatty acid modification of MA, multimerization of Gag, interaction with 
lipids such as PI(4,5)P2, and the ability of MA to sense the hydrophobic core of the 
membrane. However, there remains a great deal that we donʼt understand about these 
key signals. What are some of the critical questions and issues that remain and how 
should we begin to address them? 
 
STANDARDIZING BINDING ASSAYS 
Traditionally in vitro membrane binding studies employ a flotation assay, similar 
to the one used in the studies presented here. However, not all flotation assays are 
created equal, which is likely the source of a number of discrepancies between studies. 
These differences include the size of the sucrose gradient, ranging from 250 uL to 5 mL, 
the type of rotor used, fixed angle vs swinging bucket, and the ionic strength of both the 
binding reaction and the sucrose gradient. Arguably the most important difference 
between studies is the method used to prepare liposomes. In some studies liposomes 
have been prepared by gentle rehydration and sonication, which results in multilamellar 
membrane sheets and vesicles of varying size. Other studies extrude rehydrated 
membranes resulting in uniformly sized unilamellar vesicles. Individually each of the 
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above-mentioned methodological differences may have a small effect on the outcome of 
an experiment, but collectively these differences may add up resulting in striking 
incongruencies between studies. At a minimum it will be important for the field to take 
these experimental variations into consideration when comparing results. Ideally, 
adoption of more standardized methods of measuring protein membrane interactions 
should take place.  
 
MOVING FORWARD: HOW TO STUDY PROTEIN MEMBRANE INTERACTIONS 
MORE PRECISELY? 
A number of alternative ways to measure protein membrane interactions can be 
used. I will describe a few of them briefly, as well as some of the advantages and 
disadvantages of each. 
Fluorescence correlation microscopy 
Fluorescent correlation spectroscopy (FCS) can be used to measure the diffusion 
rate of small, fluorescently labeled molecules, proteins for example, in solution (15). 
Compared to a 100 nanometer LUV (a standard size) the diffusion of a protein is 
extremely rapid. However, if the protein is bound to an LUV, its diffusion rate will be 
dramatically decreased and the difference in diffusion rate can be measured. Two 
advantages of this method are that the measurements require only small amounts of 
material, and the measurements are many times more rapid than the traditional flotation 
method. A disadvantage of this method is that if the protein aggregates, it may be 
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difficult to tell if a slow moving fluorophore is a protein aggregate, or protein bound to an 
LUV. 
Using GUVs to study protein membrane interactions 
Unlike liposomes, which are too small to see microscopically, GUVs can be used 
to observe binding of proteins to a membrane. One advantage of this method is that 
GUVs can exhibit macroscopic phase behavior (coexisting liquid-ordered and liquid-
disordered phases). If a membrane binding protein of interest binds preferentially to the 
liquid-ordered or the liquid-disordered phase, the preference could be detected. 
Alternatively, if protein binding to a GUV induces the formation of a phase, this may also 
be detected. GUVs have been used successfully to show that multimeric HIV-1 MA 
binds preferentially to the liquid-disordered phase (9), and to show the sequence with 
which ESCRT proteins bind to sites of Gag assembly (1). A major hurdle of using GUVs 
to study electrostatic protein-membrane interactions is that phase diagrams for PS 
containing lipid mixtures do not exist. This makes the interpretation of results difficult. 
For example, if a protein binds preferentially to the liquid-disordered phase, is it binding 
because of the membrane behavior or because PS is enriched in the liquid-disordered 
phase? One drawback to using GUVs to study protein-membrane interactions is that 
GUVs are difficult and time intensive to prepare, which means that only a limited 
number of binding conditions can be tested in an economical amount of time. 
Total internal reflection fluorescence microscopy and supported bilayers 
Supported bilayers are prepared by depositing vesicles onto a solid support, such 
as a glass slide. These vesicles can form a unilamellar bilayer, which is supported by a 
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thin (5-10Å) layer of water (11). One downside of supported bilayers is the significant 
hydrodynamic coupling between the slide and the inner leaflet of the bilayer, which can 
influence the phase behavior of the membrane (11). 
Total internal reflection fluorescence (TIRF) microscopy is a method used to 
excite and visualize fluorophores at or near the plasma membrane of cells grown on 
slides or coverslips (17). The fluorophores are excited by an evanescent field, which 
occurs when light passes from a high refractive medium, such as glass, to a low 
refractive medium, such as a cell (17). Because TIRF only excites fluorophores within a 
couple hundred nanometers of the membrane-coverslip interface, the background 
fluorescence is very low. Using TIRF on a supported bilayer is similar to using TIRF to 
study a cell. The evanescent field only excites fluorescently tagged protein, Gag-GFP 
for example, near the bilayer surface. If binding of Gag to the supported bilayer results 
in Gag multimerization it should be possible to detect this by TIRF. The multimerized 
Gag, or Gag puncta, on a supported bilayer could be representative of an assembly, 
analogous to what occurs at the plasma membrane of cells during the late stage of the 
viral life cycle. If the membrane supports Gag assembly, the effects of different lipid 
components and mixtures on the rate of assembly could be tested. For example, does 
PI(4,5)P2 enhance binding of Gag as measured by liposome flotation assays, or does 
PI(4,5)P2 promote assembly of Gag? 
One drawback of this system is that some lipid mixtures do not form stable 
supported bilayers. PE-based membranes, for example, form a bilayer that, in the 
presence of protein, becomes unstable (personal communication, Gerald Feigenson 
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and Hirsh Nanda). It is possible that alternative bilayer supports may allow for the use of 
PE-based supported bilayers. However, if the negative effect of PE on the stability of a 
supported bilayer cannot be remedied, it may be possible to perform similar 
measurements using PE based GUVs. 
 
INNER LEAFLET PLASMA MEMBRANE LIPID MIXTURES 
Many Gag-membrane binding studies use a lipid mixture that is not 
representative of the lipids found in the inner leaflet of the plasma membrane, and 
therefore developing a model inner leaflet lipid mix should be a priority. For example, 
model membranes are typically made with the neutral outer leaflet lipid PC instead of 
the neutral inner leaflet lipid PE. The very large differences in head group size of PC 
and PE could dramatically alter the binding of protein. In addition, cholesterol is 
frequently not included in model membrane mixes, and neither are lipids that represent 
smaller fractions of the membrane such as sphingomyelin, plasmalogen-PE, and PI. Not 
only is a model inner leaflet lipid mix rarely used to study protein-membrane 
interactions, there is essentially no information on the phase behavior of such a lipid 
mixture. In conclusion, an inner leaflet lipid mixture should be developed and 
characterized followed by an analysis of the amount of protein binding this lipid mixture 
supports. These inner leaflet mixes should also be used in the previously described 
FCS, TIRF-microscopy supported bilayer, and GUV methods.  
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CHARACTERIZING PIP BEHAVIOR 
While we know that HIV-1 Gag membrane binding is sensitive to the presence of 
PI(4,5)P2 in membranes (2, 3, 13), and in vitro as little as 2% PI(4,5)P2 can increase 
Gag membrane binding by ten fold (7), we understand surprisingly little about how PIPs 
behave in membranes. It is never explicitly stated in publications but PIPs are generally 
presented as freely diffusing, evenly distributed lipids that do not demonstrate any 
phase behavior. However, the opposite may be true. Evidence is emerging from studies 
of model membranes, that PIPs cluster in membranes (10, 14). Strong intermolecular 
and intramolecular hydrogen bond networks drive the formation of the PIP clusters, and 
under certain conditions these clusters represent a separate membrane phase (10, 14). 
These PIP clusters may serve as specialized binding sites for retroviral Gag proteins. If 
PIP clustering proves to be a biologically relevant type of lipid organization, 
characterizing it will be extremely important. It will be necessary to determine the 
concentration at which PIP clusters form, and what the PIP concentration is in the 
clusters. Also, how does the propensity to cluster depend on other types of lipids 
present in the membrane? Finally, what effect does protein binding to the membrane 
have on PIP clustering? 
   
GAG CONFORMATION AND NUCLEOCAPSID MEMBRANE BINDING 
The binding of Gag to the inner leaflet of the plasma membrane is mediated by 
Gagʼs MA domain, but could the positively charged C-terminal NC domain also be 
involved? Size exclusion chromatography (SEC) and small angle X-ray scattering 
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(SAXS) of HIV-1 Gag show the Gag polyprotein to be in a compact, horseshoe 
conformation (4). This conformation is also observed for dimers of Gag (5). These 
conformation studies raise the possibility that both the MA and NC domain interact with 
the cellular plasma membrane prior to or during virion assembly.  
Low angle neutron reflectometry (LANR) shows that, at low ionic strength (50mM 
NaCl) both the MA and NC domains of HIV-1 Gag interact with the plasma membrane 
(5). The addition of a short oligonucleotide, too short to induce assembly of Gag into 
VLPs, results in the extension of the Gag protein (5). This extended structure is 
interpreted as MA bound to the membrane and NC bound to the oligonucleotide (5). By 
contrast, MLV Gag in solution is in a rod-like extended conformation (6), but LANR 
studies suggest that when bound to membranes, the protein also is in a horseshoe 
conformation with both MA and NC domains interacting with the supported bilayer 
(personal communication, Hirsh Nanda). Taken together these observations have led to 
a model in which both ends of Gag bind to the PM.  Upon the binding of vgRNA to NC, 
which outcompetes NC binding to the PM, Gag takes on an assembly competent 
extended conformation. One major downside of this model is that the studies that led to 
it were done with a purified HIV-1 Gag that is non-myristoylated (4, 5), because the 
myristoylated form of Gag cannot be purified in substantial amounts. But myristoylation 
is critical for membrane binding and virion assembly in vivo (12).  
Moving forward it will be critical to determine if other retroviral Gag proteins 
exhibit membrane-binding behavior similar to that of HIV-1 Gag. RSV Gag would be an 
	   	   185	  
	  
	  
	  
excellent candidate for these studies because it is not naturally myristoylated and it can 
be purified in concentrated form (unpublished data).  
If NC shows membrane binding behavior at physiological salt concentrations it 
will be important to determine if NC binding is enhanced to membranes containing 
PI(4,5)P2. NC has characteristics similar to the poly-lysine domain of the myristoylated 
alanine-rich C kinase substrate (MARCKS), a very well studied protein, and so it may be 
useful to consider the membrane binding properties of the MARCKS peptide. One 
characteristic of the highly basic MARCKS peptide is its ability to cluster PI(4,5)P2 in 
membranes (8, 18-20). If NC also clusters PI(4,5)P2, Gag binding may set up a 
membrane domain where other Gag proteins preferentially bind. This positive feedback 
could promote virion assembly. 
 
NEUTRON SCATTERING STUDIES OF PROTEIN MEMBRANE INTERACTIONS 
What happens to the membrane when a protein binds to it? One way to begin to 
answer this question employs neutron scattering techniques. Neutrons are uniquely 
suited for studying lipids and membranes. Unlike X-rays, which interact with the electron 
cloud surrounding the nucleus, neutrons interact with atomic nuclei (16). Small angle 
neutron scattering (SANS) is similar to small angle x-ray scattering (SAXS). However, 
SANS is especially sensitive to hydrogen and deuterium. Molecules containing 
increasing percentages of hydrogen−for example proteins, membranes, and 
water−have increasing scattering length densities (SLD) (16). The different SLDs of 
proteins and lipids can be contrast matched to the aqueous environment by replacing 
	   	   186	  
	  
	  
	  
water with deuterated water (16). For example, contrast-matching protein to the 
aqueous solution, between 40-45% D20, effectively makes the protein invisible. This is 
useful because it allows for the identification of patterns generated by lipids only, even 
in the presence of protein. SANS could be used to determine the effect of Gag binding 
to a membrane, such as changes to the lipid packing of the membrane.  
 
SUMMARY 
 In this chapter I have briefly described some of the remaining questions about 
retroviral Gag protein binding to membranes. I have also suggested a number of 
approaches that could be taken to begin to answer these questions. None of these 
approaches is without downsides, but if they are used in concert, those downsides can 
be minimized. 
 The binding of any protein to a membrane involves a limited number of principles. 
So the study of one protein-membrane interaction may shed light on how other proteins 
interact with membranes. Therefore future work in this field may have broad implications 
to cellular biology in general. 
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